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ClpXP Degradation System in Escherichia coli, a Study of Its Energy Sources and Its 
Applications in Managing the Expression Levels of Targeted Membrane and Soluble 
Proteins 
 
 ClpXP is an Escherichia coli (E.coli) protease that carries out energy-dependent 
intracellular proteolysis. In recent years, this system has been widely studied due to its 
importance as protein regulatory machinery and a virulence factor.  Protein substrates of 
ClpXP contain degrons with a specific protein sequence. SsrA tag is one of the five degrons 
known to designate proteins for ClpXP degradation. SsrA is an 11 amino acid peptide 
added to the C-terminus of nascent polypeptide chains translated from aberrant messenger 
RNAs lacking stop codons via a process called trans-translation.  
ClpXP was known to target only cytosolic proteins with degrons until recently, AcrB, an 
E. coli membrane protein was found to be degraded by ClpXP when it is tagged by ssrA 
peptide, which leads to the speculation that ClpXP is capable of degrading membrane 
proteins.   However, this speculation was challenged with the finding that ssrA tagging of 
ProW1−182, a different inner-membrane protein resulted in degradation by AAA+ 
membrane protease FtSH. Chapter 2 discusses our work that shows the membrane 
substrates of ClpXP bear long c-terminal cytoplasmic domains while metastable proteins 
lacking cytoplasmic domains are degraded by FtsH. For instance, ssrA-tagged Aquaporin-
Z (AqpZ), a stable tetrameric membrane protein lacking a c-terminal cytoplasmic domain, 
is subjected to degradation by neither ClpXP nor FtsH. Nevertheless, when the c-terminus 
of AqpZ is fused with ssrA- tagged Cyan fluorescent protein ClpXP degrades the resulting 
fusion protein while the truncated metastable version, AqpZ 1-155 is degraded by FtSH.  
Chapter 3 emphasizes our attempt to unravel the possible effect of proton motive force on 
the activity of ClpXP. We used Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) to 
disrupt the proton motive force. Our results suggest that degradation of soluble protein 
substrates such as GFP-ssrA, MurA-ssrA, and Chloramphenicol acetyltransferase ssrA are 
not affected by CCCP. However, degradation of membrane protein substrates by ClpXP is 
diminished in the presence of CCCP. We speculate that either the proton motive force or 
ATP provided from oxidative phosphorylation is essential, or both are important for ClpXP 
to degrade membrane proteins.   
It has been shown that the TolC is not a good target for inhibition of multidrug efflux of 
antibiotic-resistant bacteria as the bacterial susceptibility to antibiotics was not affected ev
     
 
en when a significant amount of TolC is depleted.  TolC is a membrane protein channel 
that functions in conjunction with transporters and membrane fusion proteins and provides 
a pathway to expel antibiotics across the E. coli outer membrane.  AcrAB-TolC multidrug 
efflux pump is one such example where TolC cooperates with AcrB transporter and AcrA 
membrane fusion protein.   Chapter 4 shows that depletion of the number of copies of AcrB 
makes bacteria highly susceptible to antibiotics. We utilized the ClpXP degradation system 
to regulate the copy number of AcrB in the cell. Our results show that AcrB is an excellent 
target for inhibiting multidrug efflux, and ClpXP is an excellent tool to regulate antibiotic 
target proteins for research purposes.  
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CHAPTER 1. Introduction 
1.1 Protein degradation in bacteria  
Protein degradation is an essential process to maintain protein homeostasis in live cells and 
protect them from the adverse effects caused by misfolded or damaged proteins.  The 
network of proteins involved in protein quality control in bacterial cells belongs to two 
distinct functional groups: chaperones and proteases.1 These proteins belong to two major 
families: Heatshock protein70 (HSP70) and ATPases associated with diverse cellular 
activities (AAA+).1 AAA+ proteases utilize the energy from ATP for protein unfolding, 
remodeling, degradation, and movement. Most of the Hsp proteins are involved in protein 
folding, refolding, prevention of aggregation, and disaggregation of protein1 
Chaperones are involved in the protein unfolding while proteases degrade the unfolded 
polypeptide chain into short polypeptide chains or amino acids. Examples for AAA+ 
chaperons are ClpA, ClpX, and HslU. Examples for AAA+ proteases are FtsH (HflB) and 
Lon.2 ClpA and ClpX bind with ClpP while HslU binds with HslV to function as protein 
degradation machines.2 ClpP and HslV are peptidases that cleave unfolded polypeptide 
chains without the consumption of ATP.2 FtsH and Lon structures contain both a chaperone 
domain and a peptidase domain .3 Chaperons and proteases target specific hydrophobic 
amino acid sequences in unfolded polypeptides to assist their refolding or degradation. 3 
Some specific sequences such as the ssrA tag acts as a degron to bind with chaperons. 1 
SsrA tag is an 11 amino acid peptide sequence involved in the trans-translation process 
described in 1.1.2.  
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 The structure and function of the AAA+ protease ClpXP 
When ClpA or ClpX binds with ClpP, the resulted protein degradation machinery is 
called ClpAP or ClpXP, respectively. The structure and function of the ClpXP are 
discussed as it represents a paradigm for other bacterial AAA+ protein machinery.  
ClpX is a hexameric protein unfolding machine that can function alone or with ClpP 
(Figure 1.1 A). Each subunit of ClpX is identical in sequence. Moreover, each subunit 
consists of a large and a small ATP binding domain and a family-specific N-terminal 
domain.4 The N-terminal domain contributes to substrate binding or gating function, 
allowing substrates to access other binding sites.5 ClpX hexamers consist of two distinct 
types of subunits; type 1 and type 2.4 Type 1 subunits are compatible with nucleotide 
binding, while type 2 subunits are incompatible for that. The differences of these subunits 
are determined by the conformational changes of the linkers in between the large and the 
small AAA+ domains caused by the rotation of these AAA+ domains in each subunit. 
Studies show that four subunits of the active ClpX hexamer are type1 while the remaining 
two are type 2. Therefore, ClpX hexamer binds with four ATPs even though it could bind 
with six ATPs in principle. 4 
ClpP is a tetradecameric double-ring peptidase, with each ring containing 7 subunits 
(Figure 1.1 B and C). ClpP has a proteolytic chamber of 51 in diameter with 14 catalytic 
sites. This chamber can be accessed with two axial pores having a minimum diameter of 
10Å. The interior chambers of these pores are hydrophilic and formed by residues 11-17.  
The catalytic triad of ClpP consists of Ser-97, His-122 and Asp-171.6  Each subunit of 
ClpP consists of six repeats of α/β units and an additional protruding α/β unit.  These units' 
arrangement gives ClpP monomer a  hatchet shape with a wedge-shaped head with a  short 
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handle. 6 The catalytic triad is located in a cleft at the junction of the head domain and the 
handle (Figure 1.2). 6   
ClpP alone is unable to dismantle well-folded proteins without the energy-dependent 
unfolding activity of ClpX or ClpA. Electron microscopy images show that in ClpXP 
complex, the central pore of the ClpX is aligned with the axial pore of ClpP, enabling the 
translocation of the unfolded protein into the proteolytic chamber of ClpP. 7 The 
translocated peptides in the ClpP peptidase are effectively degraded into 5-20 amino acid 
residue peptides by the high concentration of active sites in the ClpP degradation chamber.  
Substrates of ClpXP include ssrA-tagged proteins resulted from trans-translation and other 
cellular proteins containing short amino acid sequences or structural motifs called degrons, 
which mark proteins for degradation. Flynn and coworkers reported five peptide motifs 
that target protein for ClpXP degradation. 8 They also speculated that there might be 
additional classes of signals.  These peptide motifs fall into two classes: C-terminal 
peptides and N-terminal peptides.  The two types of C-terminal degrons are   C motif 1 
(ssrA tag-like sequence: Leu-Ala-Ala-COOH), C motif 2 (similar to recognition sequence: 
Arg-Arg-Lys-Lys-Ala-Ile-COOH).  The remaining three are N-terminal degrons (N 
motif1, N motif 2 and N motif 3).8  These N-terminal motifs are diverse motifs categorized 
depending on some common features. 8 The ssrA tag, a C motif 1 peptide, is one of the 






Figure 1.1 Structures of ClpX and ClpP created using UCSF Chimera9  
A. Top view of the ClpX Hexamer created from 3HWS.pdb 10 B. Side view of ClpP 
tetradecamer created from 1TYF.pdb 6 C. Top view of ClpP tetradecamer created from 










 Figure 1.2 ClpP monomer has a shape of a hatchet with a wedge-shaped head with a short 
handle.  









 The trans-translation mechanism 
In E. coli, during the translation of aberrant mRNA molecules lacking the stop codons at 
3’ end, stalled ribosome-mRNA-nascent protein complexes form.  The stalled ribosome is 
rescued by a mechanism called trans-translation (Figure 1.3).11  During trans-translation, 
first, a complex consists of Alanine-charged ssrA, SmpB, and GTP-bound elongation 
factor Tu (EF-Tu-GTP) recognize the stalled ribosome enters the aminoacyl-tRNA binding 
site (site A) of the ribosome.12 The smpB (small protein B) is an essential protein for the  
trans-translation process. The smpB-ssrA complex is required for a stable ribosome-ssrA 
RNA association. 13 The smpB interacts with bases G530, A1492 and A1493 in the small 
subunit of the ribosome, which is responsible for providing the binding site for mRNA and 
monitoring the pairing between the codon and anticodon during the traditional translation 
process.14 EF-Tu-GTP is vital for peptide chain elongation.15 In the second step of the 
trans-translation process, EF-Tu-GTP is released, and ssrA-RNA-smpB complex 
translocates to the P site, adding Alanine at the end of the nascent polypeptide chain. At 
this stage, the aberrant mRNA is released for degradation.  Then the ribosome resumes 
translation from damaged mRNA to the ssrA-RNA (tm RNA/transfer messenger RNA) 
and starts adding the ssrA peptide tag (Amino acid sequence AANDENYALAA) to the 
carboxyl terminus of the nascent polypeptide chain. 16 At the end of the trans-translation 
the ssrA-tagged peptide will be released to the cytoplasm and degraded by ClpXP or 
another protease chaperon complex and the ribosome will be released. 16 Trans-translation 
is a key process in preventing the accumulation of stalled ribosomes and degrading ssrA-





Figure 1.3 Schematic illustration of the trans-translation mechanism.  
The stalled ribosome is recognized by ssrA RNA and with the discard of the defective 
mRNA ribosome reads the ssrA coding sequence while adding the ssrA tag to the nascent 
polypeptide chain. Finally, the nascent polypeptide chain is released with the ssrA 
degradation tag and the ribosome is rescued. A, P, E sites indicate the aminoacyl-tRNA 
binding site, peptidyl-tRNA binding site and exit site of the ribosome, respectively. 
(Reprinted by permission from 12, Copyright © 2020 Springer Applied Microbiology and 
Biotechnology). 
 
 Degradation of ssrA-tagged proteins by ClpXP  
SsrA-tagged proteins are degraded by proteases such as ClpXP, ClpAP, Lon, and FtsH. 
More than 90% of ssrA-tagged proteins are degraded by ClpXP, while ClpAP contributes 
5% and Lon contributes 2%. 17 According to a study by Lies and Maurizi in 2008, FtsH 
does not significantly participate in ssrA-tagged protein degradation. However, in 2016 
Hari and Sauer reported that FtsH degrades ssrA-tagged membrane proteins in-vivo.18 
Furthermore, in 2018, Abeywansha and coworkers showed that FtsH degrades membrane 
integrated ssrA-tagged metastable proteins while it is unable to degrade well folded stable 
membrane proteins.19  This work and another study from the same group demonstrated that 
membrane-integrated ssrA-tagged proteins with a sufficient cytoplasmic domain are 
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degraded by soluble protease ClpXP , not by FtsH. 19, 20 Chai and coworkers reported for  
the first time the ability of ClpXP to degrade an integral membrane protein by 
demonstrating the degradation of ssrA-tagged multidrug efflux pump AcrB by ClpXP in 
vivo and in vitro. 20 Before the publication of this study, ClpXP was known to degrade only 
soluble protein substrates with C terminal degradation tags, including the ssrA tag .21 This 
work shows that by introducing 11 amino acid residues and the ssrA tag at the C terminus 
of the highly stable integral membrane protein AcrB, it can be subjected to degradation 
completely by ClpXP.20  Variety of model soluble protein substrates have been used in the 
functional and structural studies of ClpXP, including GFP-ssrA 22, 23, Arc repressor variants 
with ssrA tag24, titin variants with ssrA tag 25, RNase-H*-ssrA26 and λ repressor amino-
terminal domain variants with ssrA tag11 etc.  
Degradation of ssrA-tagged proteins by ClpXP protease can be described in five steps 
(Figure 1.4). The first step is the binding of ssrA-tagged substrate with ClpX in the presence 
of ATP. The two C-terminal alanine and the negatively charged α-carboxylic group of the 
ssrA tag (AA-COOH) are critical for binding with ClpX. 21 The second step is the rate-
determining step in which the proteins are unfolded by ClpX driven by the hydrolysis of 
ATP. Then the unfolded protein is translocated into the degradation chamber of ClpP. Next, 
the unfolded protein is quickly degraded by the proteolytic sites in the ClpP chamber. 
Finally, the peptide fragments resulted from degradation are released from ClpP.   
Stringent starvation protein B (SspB) is a homodimeric adaptor protein that delivers ssrA- 
tagged proteins to ClpXP. This process enhances the degradation of ssrA-tagged proteins 
by ClpXP. SspB consists of a ssrA-tagged substrate-binding domain and a ClpX binding 
module.  Therefore, SspB is a highly specific enhancing factor for the degradation of ssrA- 
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tagged proteins by ClpXP.27 ClpXP hexamer binds to one SspB dimer at a time.28 In vitro 
experiments show that the presence of SspB reduces the Michaelis constant (Km) for ssrA- 
tagged Green fluorescence protein degradation by ClpXP by a factor of 4 to 5 and 
stimulated the Vmax by about 25%. 
27 Moreover, mutagenesis experiments of ssrA tag have 
revealed that the AANDEN segment of the AANDENYALAA ssrA tag sequence is critical 
for SspB binding. 27  
 
 
Figure 1.4 Five-step degradation of ssrA-tagged protein substrates by ClpXP  
The diagram illustrates the binding of ssrA-tagged substrate with ClpX, unfolding and 
subsequent translocating of the protein into the ClpP degradation chamber, degrading the 
unfolded protein by ClpXP, and finally the releasing of the peptide fragments.  
(Reprinted by permission from 12, Copyright ©2020 Springer Applied Microbiology and 
Biotechnology). 
 




ClpXP plays a crucial role in bacterial cells. It is a vital protein quality control system in 
bacteria.29  
Several studies show that ClpXP plays a vital role in pathogenic activities. Kim and 
coworkers reported that ClpXP is essential for a type of pneumonia pathogen,  
Staphylococcus aureus, for infecting host cells. 30 ClpXP is also known to be vital for the 
growth of the pathogen Staphylococcus aureus at high osmolarity, oxidative stress, and 
low temperature.31, 32Moreover,  Farrand and co-workers found that removal of ClpXP 
from the pathogen Staphylococcus aureus alters the abundance of IsdB. This receptor binds 
with host hemoglobin and is thus critical for pathogenesis, causing severe virulence 
defects.33 ClpX is also required to initiate the daughter cell separation in Staphylococcus 
aureus. 34 These findings suggest that ClpXP is an excellent antibiotic target choice for 
specific pathogens like S. aureus.   
SsrA tag-based genetic regulation tools are widely studied in recent literature.35-40  
According to these studies ClpXP protease alone and the ClpXP- ssrA degradation system 
can be used to manipulate the pathogenic activity and reduce the expression level of 
antibiotic targets. MacGinness and co-workers demonstrated that ClpXP degrades its 
substrates 100-fold more efficiently in the presence of SspB, a protein adaptor that 
specifically enhances the ClpXP mediated degradation (described under 1.1.3) in-vitro 
systems. 35 Furthermore, they show that ssrA tag’s affinity towards ClpXP can be altered 
by changing the amino acid sequence of the ssrA tag, which will ultimately affect the 
degradation rate. 35In 2015, Brockman and coworkers used several ssrA tag variants with 
varying degradation rates dependent on the presence and absence of sspB to control the 
phosphofructokinase levels to direct glucose-6-phosphate into myo-inositol production and 
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restrict biomass formation.36 Another interesting study reports an engineered split adaptor 
system to control the degradation of ssrA-tagged proteins.38 Durante-Rodríguez and 
coworkers introduced a hybrid ssrA tag-based degradation system called FENIX to 
regulate the post-translational regulation of protein levels, which can be used as a metabolic 
switch to decouple bacteria growth from biopolymer production. 39 In 2008, Griffith and 
co-workers introduced an inducible degradation system by modifying the Escherichia coli 
and Caulobacter crescentus ssrA degradation signals and introducing them to the 3’ end 
of the genes of interest. 37 In this system, the target protein is degraded by bacterial ClpXP 
only if sspB expression is induced. 37 
Therefore, it is crucial to unravel the functional and structural properties of the ClpXP-ssrA 
degradation system as it is a versatile component that can be utilized in many protein 
applications.  
 
1.3 ClpXP and proton motive force  
ClpXP is an ATP-dependent protease. Depending on the substrate, about 20-500 ATP 
molecules per protein are  hydrolyzed for denaturation by ClpX.41 Additionally, ClpX 
spends 1 ATP molecule for translocation of 1 amino acid residue into ClpP. In cells, ATP 
is produced in glycolysis and the Krebs cycle because of substrate-level phosphorylation. 
NADH-dependent ATP synthesis is the result of oxidative phosphorylation. As described 
below in section 1.3.2, a proton motive force drives ATP synthesis via oxidative 
phosphorylation. Since ClpXP is an ATP-dependent protease, we attempted to unravel the 




 Proton motive force in bacteria  
Proton motive force is a term used to describe the free energy difference, ΔG for protons 
across the membrane. ΔG includes a term for the concentration difference and a term for 




+ 𝑍𝐹𝛥𝛹  
Where ⌊𝐻+𝑜𝑢𝑡⌋ and ⌊𝐻+𝑖𝑛⌋ are the proton concentrations on the two sides of the 
membrane, Z is the charge on the proton, F is Faraday’s constant, and 𝛥𝛹 is the potential 
difference across the membrane.  
The proton gradient across the membrane occurs due to the electron transport chain 
activities during cellular respiration. Protons are driven out of the inner membrane to the 
periplasmic space while contributing to electron transport, causing a high pH value in the 
cytoplasm relative to the periplasmic space. Consequently, the cytoplasm becomes 
negatively charged with respect to the periplasmic space. The electron transport chain 
energy is stored in an electrochemical potential created by the pH gradient and the electrical 
gradient across the inner membrane.   
In terms of the cytoplasm and the periplasmic space pH values, the free energy difference 
is   
𝛥𝐺 = −2.303 𝑅𝑇 (𝑝𝐻 𝑜𝑢𝑡 − 𝑝𝐻𝑖𝑛) + 𝐹𝛥𝛹 
The pH is always acidic outside (periplasmic space) and more basic inside (cytoplasm), 
and the membrane potential is consistently found to be positive outside and negative inside. 
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When typical values of 𝛥𝛹 = 0.18𝑉 and  𝛥𝑝𝐻 = 1 𝑢𝑛𝑖𝑡 are used, and with F= 96.485 
kJ/V.mol, the value of ΔG at 37°C is  
𝛥𝐺 = 23.3𝑘𝐽 
Which is the free energy change for the movement of one mole of protons across the inner 
membrane. According to Mitchell's model, this energy drives the ATP synthesis, which is 
described below. 
 
 How does the proton motive force drive ATP synthesis?    
According to Mitchell’s chemiosmotic hypothesis, the electron transport chain's energy 
stored in the proton gradient across the inner mitochondrial membrane drives ATP 
synthesis in cells via oxidative phosphorylation. The pH gradient and the electrochemical 
gradient drive the protons to the bacteria's cytoplasm, which is an energetically favorable 
process. The flow of protons down this electrochemical gradient through F1F0 ATP 
synthase drives the ATP synthesis. PMF and the ATP production is coupled by the F1F0 




Figure 1.5 The proton and electrochemical gradients existing across the inner bacterial 
membrane.  
The transport of protons across the membrane by complexes I, II, III and IV of electron 
transport chain generates the electrochemical gradient.  
 
 Uncouplers disrupt the coupling of electron transport and ATP synthase.  
2,4 Dinitrophenol, Dicumarol, Carbonyl cyanide-P-trifluoro-methoxyphenyl hydrazone 
(FCCP) and Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) are called uncouplers 
because they dissipate the proton gradient and uncouple the electron transport chain and 
ATP synthase. Uncouplers are hydrophobic and have a dissociable proton. These 
compounds carry protons across the inner membrane down its concentration gradient, 
diminishing the proton gradient that couples electron transport and the ATP synthase. 
When bacteria are treated with uncouplers, electron transport continues, and protons are 
driven out through the inner membrane. However, they are carried back in rapidly by the 
uncouplers preventing the ATP synthesis. Instead, the energy released in the electron 
transport is released as heat.  
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1.4 Bacteria multidrug efflux pump AcrB  
 Antibiotic resistance in bacteria  
Antibiotic-resistant bacteria are one of the greatest threats to human health. Since the 
discovery of penicillin by Alexander Fleming, large amounts of antibiotics were used to 
treat bacterial infections in humans and animals. Antibiotic resistance in bacteria has been 
developed due to many human practices such as using antibiotics in the meat industry, 
irresponsible use of antibiotics in farm animals, genetically modified food with antibiotic 
resistance genes, irresponsible use of antibiotic in a medical environment like prescribing 
antibiotics without confirming bacterial infections and not using the complete 
recommended dose schedule  of antibiotics by patients. 42 
Bacterial resistance can be inherent or acquired.  For example, gram-negative bacteria have 
inherent resistance due to protection by the outer membrane, which acts as a permeability 
barrier. Bacteria gain acquired resistance by modifying existing genetic material or 
acquiring new genetic material from another source. Bacteria acquire resistance via vertical 
gene transfer or horizontal gene transfer. Vertical gene transfer means the passing of 
resistant genes to bacteria’s progeny during DNA replication. In horizontal genes-transfer, 
resistant genes are transferred from one bacterium to another bacterium of the same species 
or different species. There are three possible horizontal gene transfer mechanisms: 
transduction, transformation, and conjugation (Figure 1.6). In conjugation, plasmids are 
exchanged when there is a direct cell-cell contact between two bacteria. Conjugation is the 
most common method of horizontal gene transfer. Transformation is the process where 
bacteria take up genetic material from the external environment. Sometimes bacteria obtain 
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antibiotic-resistant genes from viruses. This horizontal gene transfer mechanism is called 
transduction.42 
Several mechanisms may lead to bacterial resistance to antibiotics (Figure 1.7). Some 
bacteria are capable of enzymatic inactivation of selected antibiotics. In this process, 
bacteria structurally modify an existing antibiotic, so it no longer inhibits its target. Bacteria 
may also alter the antibiotic target site. Efflux pumps are another tool bacterium use to gain 
resistance. Efflux pumps transport out antibiotics from cell to extracellular space. 42 
 
 
Figure 1.6 Mechanisms of horizontal gene transfer transformation, conjugation, and 
transduction  





Figure 1.7 The mechanisms of antibiotic resistance in bacteria  
Efflux pumps, antibiotic degrading enzymes/ antibiotic-altering enzymes generated from 
antibiotic-resistant genes. (Reprinted from 42) 
 
The resistance gained without any genetic changes is called phenotypic resistance. The 
most common mechanisms are growth in biofilms, stationary growth phase, and 
persistence. However, these resistant mechanisms are impermanent. Bacteria become 
susceptible to antibiotics when these conditions change. 42 
Discontinuing the use of antibiotics in farm animals, the use of specific antibiotics to 
specific infections, stopping unnecessary antibiotic prescriptions and finishing the 
recommended dose of antibiotics by patients are possible solutions that have been proposed 
to combat antibiotic resistance . 42  
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 Antibiotic resistance caused by efflux pumps  
Efflux pumps export a wide variety of substrates, including antibiotics, out of the cells, 
reducing the intracellular concentration of antibiotics (Figure 1.8). Gram-negative bacteria 
consist of a plethora of efflux pumps. Some of them are single component efflux pumps 
(Eg:Tet pumps) which efflux drugs from the cytoplasm to the periplasmic space, while 
others are multi component efflux pumps (Eg: AcrA-AcrB-Tolc) which efflux drugs from 
cytoplasm and periplasm to the extracellular space.43 This efflux of antibiotics from the 
intracellular space leads to bacterial antibiotic resistance, which allows them to survive in 
a high concentration of antibiotics in an external medium.  Some efflux pumps can 
transport antibiotics belonging to more than one structural class causing bacteria to be 
multidrug resistant.  
There are five different families of bacterial efflux pumps. They are the adenosine 
triphosphate (ATP)-binding cassette (ABC) superfamily, the multidrug and toxic 
compound extrusion (MATE) family, the major facilitator superfamily (MFS), the small 
multidrug resistance (SMR) family, and the resistance/nodulation/division (RND) 
superfamily. 44 These efflux pumps have different energy sources. Proton motive force 
provides energy for RND, MFS and SMR pumps, MATE transporters have Na+/H+ drug 
antiport systems, while ABC transporters depend on the energy provided by ATP 
hydrolysis. 45Antibiotic resistance is one of the many functional roles performed by MDR 
pumps.44 Some of the other functional roles are involving in bacterial stress response, 
pathogenicity, and interacting with other resistance mechanisms like the membrane 




Figure 1.8 Pathways of drug influx and efflux in gram-negative bacteria  
Drug influx through the outer membrane happens through porin channels and specific 
channels and they further penetrate through the inner membrane via diffusion. Efflux of 
these drugs happens via single-component efflux transporters and multicomponent efflux 
transporters. (Reprinted with permission from 43. Copyright © 2015, American Society for 
Microbiology) 
 Structure and function of multidrug efflux pump AcrB  
Acriflavine resistance B (AcrB) belongs to the resistant-nodulation-division (RND) family 
of transporters. These transporters form tripartite complexes with membrane fusion 
proteins and outer membrane channels. AcrB transporter forms its tripartite complex with 
AcrA membrane fusion protein and TolC membrane channel (Figure 1.9). AcrB transports 
substrates from the cytoplasm to the external environment through a channel-tunnel formed 
by association with TolC.46 AcrA is a periplasmic protein that supports the interaction 




Figure 1.9 The structure of AcrA-AcrB-TolC Complex created from 5O66.pdb47 using 
UCSF Chimera9  
 
Substrates of the AcrA-AcrB-TolC complex include antibiotics like tetracycline, 
chloramphenicol, B-lactams, novobiocin, fusidic acid, nalidixic acid, and 
fluoroquinolones, detergents like SDS, Triton X-100,  bile salts, and cationic dyes, 
disinfectants and solvents.48 This tripartite complex captures substrates with hydrophobic 
domains. 43Because of its broad substrate specificity AcrAB-TolC tripartite efflux pump 
has become a target to unravel the mechanism of multidrug efflux pumps.  
 AcrB transporter is a homotrimeric integral membrane protein that can be structurally 
divided into the funnel domain (docking domain), transmembrane domain and porter 
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domain (Figure 1.9A). The docking domain is essential for AcrB trimerization. 
Transmembrane domains facilitate drug transport by energy transduction.  Each monomer 
of AcrB contains 12 transmembrane helices. Porter domains consist of the binding pockets 
(proximal and distal) and regulate substrate uptake, recognition, and translocation. 49 The 
switch loop separates the two binding pockets as shown in Figure 1.9B. The switch loop 
consists of 11 amino acids and is shown to be functionally necessary for drug efflux by 
AcrB. 50 
 The proton motive force energizes AcrB. When drugs are transported through the AcrB 
transporter, AcrB rotates through three distinct monomer confirmations: loose (L), tight 
(T), and Open (O) (Figure 1.9 C). As shown in Figure 1.9C, in the L conformation, drug 
molecules enter the proximal binding pocket. Next, conformation change occurs to the T 
state and drug molecules move into the distal binding pocket. Upon conformational change 
from T state to O, these drug molecules are transported through the exit channel and 






Figure 1.10 A. AcrB homotrimer B. AcrB monomer C. Three different monomer 
conformations AcrB achieve when engaging in drug efflux  






CHAPTER 2. Accessibility from The Cytoplasm is Critical for ssrA Tag-Mediated 
Degradation of Integral Membrane Proteins by Clpxp Protease   
(Adapted with permission from19. Copyright (2018) American Chemical Society. In this 
work, AcrB-ssrA degradation study was done by Qian Chai and included in this chapter 
for the completeness of the study) 
2.1 Introduction  
 Protein degradation is critical in preventing deleterious effects caused by damaged or 
misfolded proteins in living cells. In bacteria, ATP-dependent proteases including ClpXP, 
ClpAP, FtsH, HslUV, and Lon and ATP-independent proteins such as Tsp (also known as 
Prc) are engaged in protein degradation and preserve the homeostasis in cells.52, 53Among 
them, a well-studied example is ClpXP, a cytosolic protease complex containing a protease 
ClpP and an ATP- driven unfoldase ClpX.21, 23, 54, 55A primary function of the ClpXP 
complex is to degrade proteins bearing a ssrA tag. The ssrA tag is a degradation signal.16, 
56, 57 This signal facilitates the destruction of incomplete amino acid chains translated using 
mRNA molecules lacking stop codons as the template. These prematurely stopped 
translation events lead to stalled ribosome-peptide chain complexes in living cells. A 
tmRNA, which serves both as a tRNA and an mRNA, is recruited to add the ssrA tag at the 
end of nascent polypeptide chain and release the ribosome from the stalled complex. The 
ssrA tag is encoded by the mRNA component of tmRNA, which binds to the stopped 
translation complex and restores translation. Polypeptide chains bearing the ssrA tag are 
considered by the cell as defective products from prematurely stopped translation and thus 
are tagged for destruction. A cytosolic adaptor protein SspB assists in the delivery and 
binding of the ssrA-tagged substrate with ClpX. In addition to ClpXP, FtsH is another 
AAA+ protease that recognizes the ssrA tag.58-60 Before our discovery that ClpXP mediates 
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the degradation of AcrB-ssrA, FtsH was the only protease that had been reported to degrade 
membrane integrated proteins completely.20, 61 FtsH is a protease anchored to the 
cytoplasmic side of the inner membrane. This protease has been shown to degrade several 
integral membrane proteins with a metastable structure. FtsH has been reported to degrade 
ssrA-tagged proteins.60 Sauer and co-workers also investigated the degradation of an ssrA-
tagged membrane protein fragment that contains three transmembrane helices. They found 
that FtsH, rather than ClpXP, degraded ssrA in E. coli cells. We were the first to report that 
ClpXP could facilitate the degradation of an ssrA-tagged integral membrane protein 
AcrB.20 We confirmed that the deletion of the ClpX or ClpP gene in E. coli strain hindered 
the degradation. AcrB-ssrA was membrane integrated before degradation, as confirmed by 
reducing efflux activity after the induced expression of ClpX in a ClpX knockout strain. In 
this study, we further investigated the mechanism of the ssrA tag-mediated degradation of 
membrane proteins. Unlike FtsH, which contains two transmembrane helices that anchored 
it to the cytoplasmic membrane's inner side, ClpXP is not known to be membrane-
associated or partnered with membrane-associated proteins. For a cytosolic protease to 
dislodge and degrade an integral membrane protein, the first obstacle is to latch onto the 
sequence and dislodge the transmembrane helices from the cell membrane. Therefore, we 
speculate a C-terminal (CT) domain or tail of sufficient length, which provides a secure 
grip by ClpX and SspB, to be essential for ClpXP-mediated degradation. In this study, we 
investigated the ssrA tag- mediated degradation of four integral membrane proteins from 
E. coli to elucidate the role of the CT tail. Our first substrate, AcrB, contains 18 residues 
after the last transmembrane helix.46 We systematically shortened the tail to measure the 
effect on degradation and found that the length did drastically affect degradation efficiency. 
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The second substrate is Aquaporin Z (AqpZ), a water channel protein. AqpZ is a tetramer 
without a significant CT sequence.62 We found that it could not be degraded even when an 
ssrA tag was introduced. However, after we introduced a CT domain, the cyan fluorescent 
protein (CFP), the protein could be degraded when an ssrA tag was introduced. We also 
examined two other examples, YiiP and YajR, and truncated YiiP and AqpZ fragments. 
We found that the degradation of the ssrA-tagged membrane protein depends on the 
accessibility of the tag and the intrinsic stability of the protein.   
2.2 Materials and Methods 
 Strains and Plasmids  
Strains DL41 and BW25113 and their single-gene knockout strains were obtained from the 
Coli Genetic Stock Center (Yale University). DL41ΔclpX was created using the Quick and 
Easy E. coli Gene Deletion Kit (Gene Bridges) following the manufacturer’s instructions. 
Colony PCR was used to confirm that target genes had been replaced. Strain AR3291, 
which is deficient in FtsH, was a kind gift from Dr. Teru Ogura.63 DL41ΔclpX(DE3) was 
created using the λDE3 Lysogenization Kit (Millipore Sigma) following the 
manufacturer’s protocol. Plasmid pQE-AcrB- ssrA was created in an earlier study.20 The 
fast cloning method was used to create insertion and deletion mutations of all constructs.64 
To create the control tag-free construct, a stop codon was introduced to replace the first 
amino acid in the ssrA tag using the QuikChange site-directed mutagenesis kit (Agilent 
Technologies). All constructs were confirmed using DNA sequencing. Plasmids 




Table 2.1 Plasmids used in this study  
ID Descriptions 
pQE70-AcrB 1-1044-ssrA  AcrB residues 1-1044 followed by the ssrA tag  
pQE70-AcrB 1-1044  AcrB residues 1-1044 
pQE70-AcrB 1-1043-ssrA AcrB residues 1-1043followed by ssrA tag  
pQE70-AcrB 1-1043  AcrB residues 1-1043 
pQE70-AcrB 1-1041-ssrA AcrB residues 1-1041 followed by the ssrA tag 
pQE70-AcrB 1-1041 AcrB residues 1-1041 
pQE70-AcrB 1-1039-ssrA AcrB residues 1-1039 followed by the ssrA tag 
pQE70-AcrB 1-1039  AcrB residues 1-1039 
pQE70-AcrB 1-1038-ssrA AcrB residues 1-1038 followed by the ssrA tag  
pQE70-AcrB 1-1038 AcrB residues 1-1038  
pQE70-AcrB 1-1037-ssrA AcrB residues 1-1037 followed by the ssrA tag  
pQE70-AcrB 1-1037  pQE70-AcrB 1-1037 
pQE70-AcrB 1-1035-ssrA AcrB residues 1-1035 followed by the ssrA tag 
pQE70-AcrB 1-1035  AcrB residues 1-1035  
pQE70-AcrB1-1033-ssrA AcrB residues 1-1033 followed by the ssrA tag 
pQE70-AcrB 1-1033  AcrB residues 1-1033 
pQE70-AcrB 1-1031-ssrA AcrB residues 1-1031 followed by the ssrA tag 
pQE70-AcrB 1-1031 AcrB residues 1-1031 
pET28a-Flag-AqpZ  AqpZ preceded by a Flag tag  
pET28a-Flag-AqpZ C20S AqpZ preceded by a Flag tag and C20 is replaced by S 
pET28a-Flag-AqpZ-ssrA  AqpZ preceded by a Flag tag and followed by the ssrA tag  
pET28a-Flag-AqpZ C20S-ssrA  AqpZ C20S preceded by Flag tag and followed by the ssrA tag 
pBAD33-Flag-AqpZ 1-155 AqpZ residues 1-155 preceded by a Flag tag  
pBAD33-Flag-AqpZ1-155-ssrA AqpZ residues 1-155 preceded by Flag tag and followed by 
ssrA tag 
pET28a-Flag-AqpZ-CFP AqpZ preceded by Flag tag, followed by CFP and His tag 
pET28a-Flag-AqpZ-CFP-ssrA  AqpZ preceded by Flag tag, followed by CFP and the ssrA tag 
pET28a -Flag Yiip  Yiip preceded by a Flag tag 
pET28a-Flag-Yiip-ssrA Yiip Preceded by a Flag tag and followed by the ssrA tag 
pBAD33-Flag-Yiip-1-200 Yiip residues 1-200 preceded by Flag tag  
pBAD33-Flag-Yiip-1-200-ssrA Yiip residues 1-200 preceded by Flag tagand followed by the 
ssrA tag 
pBAD33-Flag-YajR YajR preceded by a Flag tag and followed by the ssrA tag 
pBAD33-Flag-YajR  YajR preceded by a Flag tag 









 Protein expression and purification 
ClpX, ClpP, and SspB were expressed and purified as previously reported.20 Flag-AqpZ-
CFP and Flag-AqpZ-CFP-ssrA were expressed in DL41ΔclpX. Protein expression and 
purification were conducted as described with minor modifications.20, 65 Briefly, a single 
colony from a freshly transformed plate was used to inoculate 3 mL of LB media 
supplemented with kanamycin and cultured overnight. The overnight culture was used to 
inoculate 600 mL of fresh LB media supplemented with proper antibiotics. The culture was 
incubated with shaking at 37 °C until its absorbance at 600 nm (OD600) reached 0.8, upon 
which IPTG was added to a final concentration of 100 mg/L to induce protein expression. 
Cells were harvested after 4 h of induction. Cells were lysed using sonication and protein 
was purified through its his-tag using metal ion affinity chromatography. After elution, 
samples were dialyzed against a dialysis buffer (0.03% Dodecyl beta-D-maltoside, 30 mM 
Tris, 0.5 M NaCl, pH 7.9) overnight at 4 °C to remove imidazole.  
 Protein expression test using immunoblotting 
To examine AcrB expression under basal conditions, 3 mL of E. coli cells was cultured 
overnight and collected via centrifugation. (XG, how long, temp) The cell pellet was 
sonicated (sonicator device, time, intensity) in a lysis buffer (50 mM Na- Pi pH 7.5, 100 
mM NaCl). Next, the SDS-loading dye was directly added into the lysate, and the samples 
were resolved using SDS-PAGE, followed by Western blot using an anti-AcrB antibody 
raised against a peptide sequence corresponding to residues 1032−1045 of AcrB (AcrB-
CT-antibody) or against the purified full-length AcrB (AcrB-FL-antibody).20 For full-
length (1049) and truncation constructs 1041 and 1044, we used the CT antibody since it 
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provides a superior specificity, but for shorter constructs, the CT antibody no longer binds 
to the protein. Thus, we switched to the FL antibody, which was produced using purified 
full-length AcrB as the antigen. The FL antibody is not as specific as the CT antibody, 
likely due to a trace amount of contaminations from purified AcrB used as the antigen to 
produce the antibody. Since for each truncation constructs both the control band (no ssrA 
tag) and ssrA-tagged band were detected using the same antibody, the switch of antibody 
is not expected to affect the calculated ratio of degradation. Expression of other proteins 
was examined via the Flag tag introduced at the N-terminus of the protein, right after the 
first Met residue. A total of 3 mL of fresh LB media was inoculated using 50 μL of 
overnight culture and induced when OD600 reached 0.8. The culture was incubated with 
shaking for an additional 1 h before harvesting via centrifugation. The cell pellet was 
sonicated and processed as described above before being subjected to SDS-PAGE analysis, 
followed by immunoblotting using an anti-Flag antibody (Santa Cruz Biotechnology)  
 ClpXP-SspB degradation assay  
Digestion of detergent-solubilized AqpZ-CFP-ssrA was performed as described.20 Briefly, 
purified AqpZ-CFP-ssrA was dialyzed into a phosphate buffer (50 mM Na-Pi pH 7.5, 100 
mM NaCl). To initiate digestion, AqpZ-CFP-ssrA, ClpX, ClpP, and sspB were added at a 
molar ratio of 1:2:3:1 in the assay buffer including the ATP regeneration system (25 mM 
HEPES-KOH, pH 7.6, 200 mM KCl, 10 mM MgCl2, 10% glycerol, 2 mM DTT, 5 mM 
ATP, 16 mM creatine phosphate, and 0.032 mg/mL creatine kinase) supplemented with 
0.03% Dodecyl beta-D-maltoside.  A control sample was also set up containing AqpZ-CFP 
rather than AqpZ-CFP-ssrA. For real-time fluorescence detection, fluorescence intensity 
was monitored using the PerkinElmer LS 55 fluorescence spectrometer at 30 °C with 
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excitation and emission wavelengths of 435 and 475 nm, respectively. For anti-Flag 
Western blot analysis, an identical sample was set up in parallel, and at the indicated time 
points, aliquots of the sample were collected and put on ice. SDS-loading dye was 
immediately added into the samples to stop the reaction. The samples were then analyzed 
using SDS-PAGE followed by immunoblotting using anti-Flag antibody.  
 Preparation of membrane vesicles and fluorescent 
spectroscopy 
To rule out the possibility that the introduction of CFP at the C-terminal affected the 
membrane integration of AqpZ, soluble component and membrane vesicles were separated 
to examine the location of the fusion protein. After protein expression was induced, cells 
were harvested by centrifugation and resuspended in 20 mM Tris-Cl (pH 8.0) and 100 mM 
NaCl. After sonication to lyse the cells, the mixture was first centrifuged at a low speed 
(5000g,10 min) to remove cell debris. Next, the supernatant was centrifuged at 100000g 
for 1 h to collect membrane vesicles. The supernatant contains cytosolic proteins. The 
membrane vesicle was resuspended in 20 mM Tris-Cl (pH 8.0) and 100 mM NaCl 
containing 1% Triton (X-100?). Fluorescence spectra were collected for both samples with 
an excitation wavelength of 435 nm. The samples were also subjected to anti-Flag Western 
blot analysis as described.  
2.3 Results and discussion  
 Degradation of AcrB-ssrA  
The length of the CT tail is important for the degradation of AcrB-ssrA. AcrB is a large 
trimeric integral membrane protein, with 12 transmembrane helices in each subunit. The 
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last transmembrane segment, TMH12, ends with three Arg residues, R1030−R1032, 
followed by 17 additional residues 1033−1049 (Figure 2.1A). This tail is expected to be 
quite flexible, since residues after 1034 are routinely missing from the crystal structures of 
AcrB, indicating an unstructured sequence. To examine the dependence of degradation on 
the length of the C-terminus tail, we created a series of truncated AcrB pairs: one bearing 
the ssrA tag after the indicated amino acid, and the other containing a stop codon after the 
indicated amino acid. These plasmids were transformed into DL41ΔacrB, and the 
expression levels of AcrB were detected using anti-AcrB antibody. Representative blots 
were shown in Figure 2.1B. The top panel of blots (full-length AcrB, 1044 and 1041 
constructs) was detected using the anti-AcrB CT antibody, while the lower panels were 
detected using the anti-AcrB FL antibody. The level of degradation, which is the difference 
between the relative intensity of the corresponding pair, was determined and summarized 
in Figure 2.1C. The shortening of the tail has a significant effect on the level of degradation. 
The last five residues (1045−1049) seemed to be dispensable. The ssrA tag attached 
immediately after residue 1044 could still facilitate complete degradation of the protein. 
However, any additional truncation, even by one residue, significantly hampered the 
efficiency of degradation. When the ssrA tag was attached after residue 1031, the 





Figure 2.1 Degradation of AcrB-ssrA  
(A) Sketch of the AcrB secondary structure. The yellow block indicates the location of the 
membrane. After the last transmembrane helix is the beginning of the CT tail that contains 
R1031−H1049. Residues in black indicated positions for which truncation was tested. (B) 
Anti-AcrB Western blot analyses of membrane extract obtained from DL41ΔacrB 
containing plasmids encoding the indicated constructs. The three constructs in the top row 
were detected using the CT antibody, while the bottom two rows of panels were detected 
using the FL antibody. The gray arrow indicates a nonspecific band when the FL antibody 
was used in the detection, while the black arrow indicates the AcrB constructs. (C) Level 
of degradation calculated from band intensities as shown in B from three independent 
experiments. The average value and standard deviation are shown.  
 
 Degradation of AqpZ-ssrA  
AqpZ bearing an ssrA tag is not degraded in E. coli Cells. If the length of the CT tail is so 
important, then an integral membrane protein with a short CT sequence should resist 
ClpXP-facilitated degradation. To examine this hypothesis, we chose a well-characterized 
tetrameric membrane protein, AqpZ (Figure 2.2A). AqpZ does not have a significant CT 
tail. After the last transmembrane helix, there are just four residues, EKRD. We first created 
an AqpZ construct with an NT Flag tag for detection and then introduced the ssrA tag at 
the CT. Since ssrA tag-facilitated degradation is successive in nature and starts from the 
CT sequence, the Flag tag at the NT will allow us to identify potential partial degradation 
products generated in the process of degradation. Flag-AqpZ-ssrA can be expressed at a 
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similar level as Flag-AqpZ in E. coli cells, as revealed from the anti-Flag immunoblotting 
analysis of cell lysate prepared from DL41 expressing the two constructs (Figure 2.2B, 
lanes 1 and 2). AqpZ forms a tight tetramer, a large portion of which remains associated 
even in SDS-PAGE analysis.62 This can also be seen in Figure 2.2B, lanes 1 and 2. To 
investigate the possibility that the existence of a tetrameric structure led to a resistance to 
degradation, we introduced a C20S mutation. This single mutation has been shown to 
dissociate tetramers into monomers.66 We then examined the degradation of Flag-
AqpZC20S-ssrA. As shown in Figure 2.2B (lane 3), the tetramer band disappeared as 
expected, but the monomer band was still visible. This result clearly showed that the stable 
quaternary structure was not the reason behind the resistance of Flag-AqpZ-ssrA to 
degradation. The introduction of a CT soluble domain enabled the degradation of AqpZ. If 
the resistance to degradation is due to the lack of a CT tail for ClpXP to grip onto, then the 
introduction of such a domain should enable degradation. We tested this hypothesis by 
creating a fusion protein Flag-AqpZ- CFP. We choose CFP as the CT soluble domain, since 
the degradation can then be readily monitored using fluorescence. Degradation of GFP-
ssrA by ClpXP-SspB has been intensively studied.3, 67-69Therefore, CFP-ssrA is expected 
to be a good ClpXP substrate. We compared the expression of Flag-AqpZ- CFP and Flag-
AqpZ-CFP-ssrA in DL41 (Figure 2.2C, lane 1 and 2). A band corresponding to the 
combined molecular weight of AqpZ and CFP could be observed from the Flag-AqpZ-CFP 
sample in anti-Flag WB (lane 1), while the band was missing in Flag-AqpZ-CFP-ssrA (lane 
2). We did not observe partially digested fragments of a significant intensity on the blot, 
indicating that degradation did not stop before the AqpZ domain. Since the Flag tag is at 
the NT of the construct, if large fragments resulting from a partially degraded protein do 
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exist, a ladder of fragments should be visible on the gel. This result indicates that the 
addition of the CFP module at the CT facilitated complete degradation of AqpZ. We next 
examined the expression of Flag-AqpZ-CFP-ssrA in a clpX knockout strain, DL41ΔclpX 
(lane 3). It expressed at a similar level as Flag-AqpZ-CFP in the wild-type strain. Thus, 
ClpXP is involved in the degradation of the fusion protein. To confirm that the introduction 
of the CFP domain at the CT does not affect the folding and membrane insertion of AqpZ, 
we cultured DL41ΔclpX transformed with plasmids encoding Flag-AqpZ-CFP or Flag-
AqpZ-CFP-ssrA. One hour after protein expression was induced, we separated cell 
components into soluble fractions and membrane vesicles. We next used fluorescence 
spectroscopy and anti-Flag immunoblotting to locate the fusion proteins (Figure 2.3A). We 
found that both the signature fluorescence of CFP and the presence of the Flag tag were 
associated with the membrane fractions, indicating that the proteins are membrane 
integrated. Thus, the introduction of CFP enabled degradation, and it is not due to the 
disruption of AqpZ membrane integration. Degradation of Flag-AqpZ-CFP-ssrA Using 
Purified Enzymes. To further confirm that ClpXP-SspB can completely degrade Flag-
AqpZ-CFP-ssrA, we expressed and purified Flag-AqpZ-CFP-ssrA, as well as ClpX, ClpP, 
and SspB. Degradation was conducted as described in Materials and Methods. Protein 
degradation was monitored using both fluorescence intensity and anti-Flag 
immunoblotting. While the introduction of the CFP domain enables the monitoring of the 
degradation process in real-time, it could not signal the degradation of the AqpZ part. 
ClpXP-SspB facilitates degradation in a progressive manner and breaks the substrate down 
into small peptides of 7−9 residues. The presence of the ssrA tag is required to initiate this 
process. Once degradation stopped in the middle of the degradation and the ClpXP 
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complex dissociated from the substrate, the leftover fragment will no longer be degraded 
by ClpXP since the ssrA tag is now lacking. We set up the assay for continuous monitoring 
using a fluorescent spectrometer at excitation and emission wavelengths of 435 and 475 
nm, and from an identical sample prepared in parallel, aliquots of the sample were collected 
for Western blot analysis (Figure 2.3B, C). Under the current experimental condition, the 
fluorescence of Flag-AqpZ-CFP-ssrA was reduced to a ground level of ∼10% within 15 
min, which was consistent with the anti-Flag Western blot analysis. In contrast, without 
the ssrA tag, Flag-AqpZ-CFP was stable over the same period of time and no degradation 
could be observed. The ssrA tag facilitated the degradation of two other integral membrane 
proteins with intrinsic CT domains.  
 
Figure 2.2 Degradation of ssrA-tagged AqpZ.  
(A) Structure of AqpZ tetramer created from 1RC2.pdb using Pymol.62 The yellow box 
highlights the location of the membrane. The chains are colored according to the secondary 
structural succession, with blue and red corresponding to the NT and CT, respectively. (B) 
Anti-Flag Western blot analysis of samples prepared from DL41 expressing AqpZ (1), 
AqpZ-ssrA (2), and AqpZC20S-ssrA (3). Positions of monomer (M) and tetramer (T) are 
marked. (C) Anti-Flag Western blot of samples prepared from DL41 expressing AqpZ-
CFP (1) and AqpZ-CFP-ssrA (2) and from DL41ΔclpX containing AqpZ-CFP-ssrA (3). 
From top to bottom, molecular weights of marker bands are 75 (red), 63, 48, 35, 25 (green), 








Figure 2.3. Degradation of Flag-AqpZ-CFP-ssrA by ClpXP-SspB in a reconstituted 
system.  
(A) CFP did not affect membrane integration of AqpZ. Fluorescence spectra of soluble 
component (gray and blue) and detergent-solubilized membrane vesicles (red and black) 
prepared from DL41ΔclpX expressing Flag-AqpZ-CFP (black and gray) or Flag-AqpZ-
CFP-ssrA (red and blue). The panel on the top is the anti-Flag Western blot analysis of 
cytosols (C, lanes 2 and 4) and membrane vesicles (M, lanes 1 and 3) prepared from 
DL41ΔclpX expressing Flag-AqpZ-CFP (1, 2) or Flag-AqpZ-CFP-ssrA (3, 4). (B) 
Fluorescence intensity of Flag-AqpZ-CFP-ssrA was monitored over time upon the 
initiation of degradation by ClpXP-SspB (black). As a control experiment, Flag-AqpZ-
CFP-ssrA was replaced by Flag-AqpZ-CFP, while all other conditions were kept identical 
(red). (C) Anti-Flag Western blot analysis of samples collected at the indicated time into 
degradation. Lanes 1−3 are samples collected for Flag-AqpZ-CFP, and lanes 4−9 are 
samples collected for Flag-AqpZ-CFP-ssrA.  
 
 
 Degradation of YiiP-ssrA and YajR-ssrA  
Next, we examined two other proteins that naturally contain CT domains, YiiP and YajR 
(Figure 2.4). YiiP is a dimer, while YajR is a monomer.70, 71Similarly to AqpZ, to facilitate 
detection, we introduced a Flag tag at the NT of the proteins, right after the first Met. We 
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found that the introduction of the ssrA tag facilitated the degradation of these proteins, and 
the deletion of the ClpX gene from the strain restored expression, like what has been 
observed previously in the case of AcrB. When not cytosolically exposed, the ssrA tag may 
facilitate the degradation of a metastable membrane protein fragment by FtsH. To further 
confirm the importance of a CT tail/domain in ClpXP-facilitated degradation, we created 
a truncated version of YiiP, in which the ssrA tag was introduced right after residue 200, 
which is located at the end of the last transmembrane helix. Thus, the resultant construct 
represents the transmembrane domain of YiiP. When introduced into DL41, this construct 
could be expressed at a level like the full-length YiiP (Figure 2.5A, lane 1). Next, the ssrA 
tag was introduced right after residue 200, followed by a stop codon. When transformed 
into DL41, no protein expression could be detected (lane 2). Flag- YiiP1−200-ssrA was 
completely degraded. To examine if ClpXP- SspB is involved in the degradation, we 
examined its expression in DL41ΔclpX (lane 3), as well as in DL41ΔclpA, DL41ΔclpP, 
and DL41Δprc (not shown). Similarly, no expression was observed in any of these strains. 
Finally, we transformed the strain AR3291, which is deficient in FtsH (lanes 4 and 5). 
When plasmid encoding Flag-YiiP1−200 or Flag-YiiP1−200-ssrA into the ssrA tag was 
present, the protein was completely degraded in DL41 and DL41ΔclpX, but not in AR3291. 
In this case, FtsH was responsible in degrading YiiP1−200-ssrA. Next, we created a 
truncated construct of AqpZ by inserting a stop codon after residue 155, which is in the 
short cytosolic loop before the last two transmembrane helices CT of the full-length AqpZ, 
which is also a very stable membrane protein, it was not degraded. In contrast, in YiiP, the 
CT domain is important for protein dimerization and thus may have a large impact on the 
overall protein.70 Without the CT domain, YiiP1−200 is not stable enough to resist 
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degradation by FtsH. Similarly, in AqpZ 1−155, the last two transmembrane helices are 
removed. As revealed by the crystal structure, the last two helices are clearly important for 
the overall structure and folding of AqpZ. Thus, although the wild-type AqpZ is very 
stable, the fragment lacking the last helices is not and can be degraded by FtsH when tagged 
with the ssrA sequence. This observation is consistent with a recent study of Sauer et al., 
in which the ssrA tag was introduced at the CT of truncated E. coli ProW1−182, which 
contains an N-terminal periplasmic domain, three transmembrane segments, and cytosolic 
C-terminus (with two added lysines).18 They discovered that FtsH degraded ssrA-tagged 
ProW1−182 in vivo. In contrast, both ClpXP and FtsH degrade it in vitro. The presence of 
the membrane in vivo was also proposed as the barrier that limited the accessibility of the 







Figure 2.4. Degradation of Flag-YajR-ssrA and Flag-YiiP-ssrA.  
Structures of the YiiP dimer (created from 2QF1.pdb using Pymol70) and YajR (created 
from 2WDO.pdb using Pymol71) monomer are shown, with the yellow box indicating the 
position of the transmembrane domains. The structures are colored according to the 
secondary structure succession. Lane 1 is Flag-YajR or Flag-YiiP expressed in DL41. Lane 
2 is Flag-YajR-ssrA or Flag-YiiP-ssrA expressed in DL41. Lane 3 is Flag-YajR-ssrA or 
Flag-YiiP-ssrA expressed in DL41ΔclpX. Bands in molecular weight markers are labeled 










Figure 2.5. FtsH is involved in the degradation of ssrA-tagged membrane proteins.  
(A) Representative images of anti-Flag Western blot analysis of Flag-YiiP1−200 (lane 1) 
and Flag-YiiP1−200-ssrA (lane 2) expression in DL41 and Flag-YiiP1−200-ssrA 
expression in DL41ΔclpX. Bands in molecular weight markers are labeled (kD). Lanes 4 
and 5 are Flag-YiiP1−200 or Flag-YiiP1−200-ssrA expression in AR3291, respectively. 
Negative and positive signs indicate the absence or presence of an ssrA tag in the construct. 
(B) Topology model of AqpZ showing the transmembrane helices as blue bars and 
membrane location as an orange box. The location of K155 is highlighted by a star. The 
panels are representative anti-Flag Western blot images of Flag-AqpZ1−155 (−) or Flag-
AqpZ1−155-ssrA (+) expression in the indicated DL41 knockout strains except for the last 




2.4 Conclusion  
The ClpXP protease complex is a soluble protease capable of degrading membrane 
integrated proteins bearing the ssrA tag. However, a critical factor in enabling efficient 
degradation is that the tag needs to be well-exposed and accessible from the cytosol, either 
at the end of a long flexible loop or at the end of a CT soluble domain. The intrinsic stability 
of the substrate protein is not as important since, once initiated, the ClpXP complex can 
fully degrade highly stable proteins including AcrB and AqpZ. In contrast, when the ssrA 
tag was not well- exposed and was beyond the reach of SspB and ClpX, FtsH could take 
over and degrade the ssrA-tagged protein if the protein is metastable. Highly stable integral 
membrane proteins, even bearing the ssrA tag, resist degradation if the tag is not accessible 




CHAPTER 3. Effect of Proton Motive Force on the Enzyme Activity of ClpXP Complex  
3.1 Introduction 
In a previous study, the relationship between proton motive force and the AAA+ membrane 
protease FtsH has been reported.72 According to this study, when the proton motive force 
(PMF) is disrupted by uncouplers CCCP and 2,4 DNP the proteolytic activity of FtsH on 
membrane protein substrates YccA, F0a, and the cytoplasmic substrate σ
32 are diminished, 
showing evidence that FtsH depends on the proton motive force. Furthermore, they created 
an FtsH derivative,  Zip-FtsH(ΔTM), by replacing the N-terminal transmembrane domains 
of FtsH with the leucine zipper73  to test the roles of the transmembrane domains on the 
dependence of PMF. Zip-FtsH(ΔTM) is a soluble derivative of FtsH and only capable of 
degrading cytoplasmic substrates.  Interestingly, degradation of σ32 by Zip-FtsH(ΔTM) is 
barely affected by CCCP.    This work shows that the transmembrane domain of the FtsH 
is vital for its dependence on the PMF.  Even though the authors have not addressed CCCP's 
possible effect on the disruption of ATP synthesis, their work with Zip-FtsH(ΔTM) proves 
that FtsH can function with the ATP supply from substrate phosphorylation. This study 
motivated us to investigate if the PMF affects the same way on activity of AAA+ cytosolic 
protease ClpXP as on Zip-FtsH(ΔTM). Moreover, ClpXP unfolds and degrades proteins at 
the expense of about 20-500 molecules of ATP, depending on the substrate's complexity. 
41 We were interested in finding out if the PMF affects the various substrates of ClpXP.  
We utilized several membrane-bound and soluble protein substrates to investigate this.   
We utilized radioactive pulse-chase method to study the degradation of membrane protein 
substrates AcrB-ssrA and YajR-ssrA in CCCP's presence and absence. Furthermore, we 
studied the ClpXP degradation of soluble protein substrates GFP-ssrA , MurA-ssrA, and 
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Chloramphenicol acetyltransferase ssrA. In vivo degradation of the cytosolic protein 
substrate, plasmid-borne Green Fluorescence Protein ssrA (GFP ssrA) was studied in 
CCCP's presence and absence. The protein was purified from the bacterial samples 
collected at different time points, resolved using SDS-PAGE and the fluorescence image 
was observed.  
MurA is an essential cytosolic enzyme in E. coli for peptidoglycan biosynthesis.74 
Degradation of MurA causes cell lysis and this can be measured through the decrease in 
optical density. 75 We choose MurA as a model substrate because its degradation could be 
monitored conveniently by measuring optical density.   
Chloramphenicol acetyltransferase (CAT) is the enzyme responsible for acetylation of 
Chloramphenicol antibiotic which causes bacterial resistance to this antibiotic. We studied 
the degradation of CAT-ssrA by ClpXP  in the presence and absence of CCCP by studying 
bacteria's resistance to Chloramphenicol.  
We also studied the effect of CCCP on the cellular ATP concentration using Molecular 
probes TM ATP determination kit (Catalogue number A22066). This assay is a 
bioluminescence assay for the quantitative determination of ATP, which utilized 
recombinant firefly luciferase and luciferin. Luciferase reacts on its substrate luciferin in 





3.2 Materials and methods  
 Plasmids and strains  
PET28a CAT and pET28a CAT-ssrA (Kanamycine resist) were created by inserting the 
Chloramphenicol acetyltransferase (CAT) gene to pET 28a vector using Fast cloning 
method.64 PET 21b GFP was created by inserting a stop codon before the ssrA tag of pET 
21b GFP-ssrA (Ampicillin resist) using Quick Change site directed mutagenesis. PECT3 
plasmid75 was obtained from Addgene (Addgene plasmid #75450). Pdt3 tag 75in 
the pECT3 plasmid was replaced by ssrA tag using a fast cloning method64 to 
create pECT-ssrA plasmid (Kanamycine resist). Primers used to insert the ssrA 
tag into the pECT3 plasmid are GAA AAC TAC GCG CTG GCA GCG TAA CCG 
CGG AGG AGA AAG TAC CAT GAT TC and CAG CGC GTA GTT TTC ATC GTT 
CGC CGC CTG CCC GCT TTC. The Q5® High-Fidelity DNA Polymerase from NEW 
ENGLAND BioLabs was used for PCR reactions. The PCR products were transformed 
into One Shot™ PIR1 Chemically Competent E. coli. Next, the plasmids were purified and 











 Genomic insertion of ssra tag into the Mura protein  
The kanR cassette flanked by FRT sites and the linear homology arms to MurA protein was 
amplified using Polymerase chain reaction (PCR) using pECT-ssrA plasmid as the 
template. Q5 polymerase was used for the PCR. Primers used were CTG CGC GCT TTA 
GGT GCA AAT ATT GAG CGT GTG AAA GGC GAA GCG GCG AAC GAT GAAA 
AC and CTG GCG GTA GCC CCG CGA ACG GGG CTG CCA GCT CTC AGA CGA 
TTA TGT AGG CTG GAG CTG C.  The linear PCR products were purified using Exo-
SAP-IT reagent and electroporated into the ΔClpX DL41(DE3) strain containing RED/ET 
expression plasmid (pRedET plasmid) and plated.  pRedET plasmid was obtained from 
Gene Bridges Quick and Easy E. Coli Gene deletion Kit.  The insertion was confirmed by 
colony PCR and sequencing. Eight colonies were picked, and colony PCR was performed 
to confirm the presence of MurA insertion using Taq DNA polymerase. The same primers 
used for homology amplification (the expected length of the product is 1448 bp). The PCR 
samples were resolved in a 0.6% agarose gel (Figure 3.3). Three colonies were confirmed 
to contain the insertion. The insertion of ssrA tag was also confirmed by sequencing (figure 





     
 
  
Figure 3.1 PCR products from colony PCR were resolved in an agarose gel. The samples 
with the expected DNA band are highlighted using a black rectangle.  
 
Figure 3.2 Sequencing results of the mutated part of the gene.  



























 In-vivo degradation of MurA-ssrA  
 The pBAD33 ClpX plasmid (Chloramphenicol resist) was transformed into the ΔClpX 
DL41(DE3) strain with genomic MurA-ssrA mutation. MurA-ssrA ΔClpX DL41 (DE3) 
with PBAD 33 ClpX in LB-Chloramphenicol media was grown at 37°C in an incubator 
shaker. Next day overnight cultures were diluted 50 times; MurA-ssrA ΔClpX DL41 (DE3) 
transformed PBAD 33 ClpX- in LB-Cam. In a 48 well plate samples were prepared. The 
samples were incubated at 37°C in the incubator shaker. OD600 was measured every 15 
mins. 20 µM CCCP /40 µM CCCP and 0.4% Arabinose were added to relevant samples at 
the early exponential phase (OD~0.2). Four replicates were taken for each reading and the 
average value is presented.   
 
 Preparation of growth medium  
One concern was the possible deleterious effect of CCCP on the growth of the E.coli cells 
when the CCCP was present in the growth media for a prolonged time. To overcome this 
concern we used the growth medium introduced by Kobayashi et al.76 when possible.  We 
have named this growth medium as growth medium X for clarity. E. coli can grow in the 
presence of a protonophore like CCCP when the growth medium contains glucose and the 
pH is 7.5 at 37℃. 76 Nutritional rich Growth medium X was made as mentioned in 76 by 
adding 50 mM Tris buffer, 10 g of tryptone, 5 g of yeast extract, 5 mM K2HPO4, and 0.5% 




 Pulse chase  
Single colonies with plasmids expressing relevant proteins were inoculated in 5 ml of LB 
and cultured overnight. Overnight cultures were diluted into 30 ml of fresh LB media next 
day. When OD 600 nm reached 0.8-1.0, cells were harvested at 4000g for 10 min at room 
temperature.  Cells were resuspended in 30 ml M9 medium (5* M9 stock 6 mL, 20% 
Glucose 600 uL, 1M MgSO4 300 uL, 0.1M CaCl2 30 uL, thiamine, biotin, and the 
respective antibiotic) and grown overnight with shaking at 37⁰C. The next day cells were 
harvested at 4000xg for 10 min at room temperature and resuspended in 6 ml of M9 
medium with 50 ug/mL of each amino acid except methionine. Then 1 mM IPTG was 
added and incubated with shaking at 37 ºC for 20 min. 35S-radioactive methionine was 
added to each sample (how much) and the pulse step was completed (pQE 70 AcrB 
YALLA-4 min, Yajr-ssrA 1 min). For the relevant samples 3/1000 volume of 10mM CCCP 
dissolved in DMSO was added followed by non-radioactive methionine final concentration 
of 2.5 mg/mL (~20 mM) incubating at 37 ºC. At different time points, 1.1 mL of culture 
was collected and immediately harvested cell (13000g, 1 min) and the supernatant was 
removed. The pellet was resuspended in 200 uL buffer A (50 mM Tris, pH 8.0, 100 mM 
NaCl, 2 mM EDTA, 0.1% TX100) and frozen using dry ice. 1/10th volume of freshly made 
10mg/ml lysozyme was added. The sample was incubated shaking for 30 min at 37 ºC and 
then frozen in dry ice for about 5 min. Next, 1/10 volume of 1mg/ml DNAse dissolved in 
1M MgSO4 was added and incubated at 37ºC with shaking for 10 minutes. The samples 
were centrifuged at 13000 g for 2 min. The membrane pellet was collected. The membrane 
pellets were resuspended in buffer B (50 mM Tris, pH 8.0, 100 mM NaCl, 1.5% TX100). 
Then the resuspensions were shaken at room temp for 1 hour. Detergent extractions and 
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soluble lysates were collected and about 50 µl Ni-NTA beads were added and shaken at 
room temperature for 60 minutes. The Ni bead suspension was centrifuged, and the 
supernatant was removed. Then 80 uL of 2x SDS loading dye supplemented with 500 mM 
imidazole was added. Next, 35 uL of the eluate was loaded onto 12% SDS-PAGE gel and 
resolved. Then the gels were fixed in 3% Glycerol, 10% glacial acetic acid, 20% Methanol 
and dried using a Vacuum gel dryer.  The gels were stored overnight inside cassette to 
transfer radioactive protein bands into the intensifying screen. The next day the intensifying 
screen is scanned using TyphoonTM FLA 9000 imager.   
 GFP-ssra degradation  
pET 21b GFP-ssrA was transformed into DL41(DE3) and ΔClpX DL41(DE3) competent 
cells and pET 21b GFP plasmid was transformed into DL41(DE3) cells and plated on LB-
Amp plates. The next day single colonies with each plasmid expressing relative protein 
were inoculated in three, 5ml of LB-Amp overnight cultures. Overnight cultures were 
diluted 25 times into fresh LB-Amp media the next day. When the OD600 was about 0.4, 
Cultures were induced with 1mM IPTG and shaken again for 30 minutes at 37°C incubator 
shaker.   Next, cultures were centrifuged (3000 g X 15 min) and washed twice with LB-
Amp to remove IPTG. Then the cell pellet was resuspended in a Growth medium X-Amp 
culture. Three GFP-ssrA cultures were made with 20 µM CCCP, 40 µM CCCP and without 
CCCP. All the cultures were shaken at 37°C in an incubator shaker. 1 ml of each sample 
was collected at 0 min, 30 min, 60 min, 90 min, and 120 min time points. The pellet was 
resuspended in 30 uL Tris buffer (50 mM Tris, pH 8.0, 100 mM NaCl, 2 mM EDTA, 0.1% 
TX100) and frozen using dry ice. Then 3 ul of freshly made 20mg/ml lysozyme was added. 
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The sample was incubated shaking for 20 min at 37 ºC and then frozen in dry ice for about 
5 min. Next, 3 ul of 1mg/ml DNAse dissolved in 1M MgSO4 was added and incubated at 
37ºC with shaking for 10 minutes. The samples were centrifuged at 13000 g for 2min. The 
supernatant was collected and allowed to bind to 25µl of Ni-NTA beads for 1h. Then 
protein was eluted using 500mM imidazole. The samples were resolved using 12% SDS 
gels. A fluorescent image (GFP) was taken using Bio-Rad gel documentation system. 
 Antibiotic activity assay   
PET28a CAT and pET28a CAT-ssrA plasmids were transformed into ΔClpX DL41(DE3) 
strain and DL41(DE3) WT strain and plated on LB-Agar-Kan plates. These plasmids 
express Chloramphenicol acetyltransferase upon induction with IPTG.   First, the highest 
concentration of CCCP that did not affect the growth of pET 28 a cat-ssrA plasmid 
transformed in ΔClpX DL41(DE3) strain (positive control) was determined. For this, a 
single colony was inoculated into a 5 ml overnight culture. The next day, the OD600 of the 
overnight culture was measured, and then cells were diluted and a 25ug/ml concentration 
of chloramphenicol and 1mM IPTG were added in growth medium X. The initial 
concentration of cells was 5*10
5 
cells/ml.    Cell growth was tested in 10 uM, 20uM, 30 
uM, 40 uM, and 50 uM concentrations. The cells were grown in 48 well plates in a 37-
degree incubator shaker for 20 hours. Four replicates were done for each CCCP 
concentration. The results showed that 20 uM is the highest CCCP concentration that did 
not affect the growth of the positive control. (Figure 3.2) This CCCP concentration was 







Figure 3.3 20 uM is the highest concentration of CCCP that did not affect the growth of 
the positive control- pET28a cat-ssrA plasmid transformed in ΔClpX DL41(DE3) 
  
  
The experiment was repeated in 20 uM CCCP with pET28a Cat-ssrA plasmids transformed 
into ΔClpX DL41(DE3) strain and DL41(DE3) WT controlling each component added to 
test the Chloramphenicol resistance of each strain. After 20 hours, the growth of cells was 
visually observed and then the OD600 was read using a microplate reader. Four replicates 
of each experiment were done.  
Then the minimum inhibitory concentration (MIC) was tested for Chloramphenicol 
resistance. For this 5 ml LB-Kan overnight cultures were prepared for pET28a Cat-ssrA in 
ΔClpX DL41(DE3) strain and DL41(DE3) WT strain and pET28a Cat in DL41(DE3) WT. 
The next day OD600 was measured in the overnight culture. The cells were diluted in 1mM 
IPTG and 20uM CCCP added nutrient-rich media X. The initial concentration of cells was 
5X105 cells/ml. Cell growth was tested at different chloramphenicol concentrations (100, 
50, 25, 12.5, 6.25, 3.125, and 1.563 ug/ml) in 48 well plates. The OD600 was recorded after 





 ATP assay to determine the amount of ATP in cells in the absence and the 
presence of CCCP  
This experiment was done to study the ATP level in cells in the presence of CCCP. Strains 
used were DL41 (DE3) cells (WT), DL41 (DE3) cells (ΔClpX) and DL41 (DE3) cells with 
MurA-ssrA mutation (MS). First, overnight cultures were prepared. The next day overnight 
cultures were diluted in the new LB medium. When the OD600 was around 0.2, 20uM 
CCCP was added to relevant samples. 1 ml of liquid cell cultures were collected at different 
OD600, centrifuged, and the cell pellet stored at -80°C until used.  
Invitrogen Molecular Probes TM ATP determination kit (Catalogue number A22066) was 
used.  The reagent was prepared according to the instructions of the user guide of the kit. 
Then the standard reaction mixture was prepared following the instruction of the user 
guide. The standard reaction mixture contains water, reaction buffer, DTT, D-Luciferin 
and firefly luciferase. A series of ATP samples were prepared in the following 
concentrations (Table 3.1).   







Before the experiment, cell pellets were thawed at the ice and lysed according to the method 
of Yang and coworkers.77 For cell lysis, first, boiling water was prepared. Then, 1 ml of 











the boiling water was added to the cell pellet and vortexed. Then the cell lysate was 
incubated on ice.  
Then 90 ul of the standard reaction mixture was placed in a white color 96 well plate and 
the background luminescence were measured using BioTek Synergy H1 Hybrid Multi-
Mode Microplate Reader/ luminometer with Gen5 Software. Then the 10 ul of each ATP 
standard solution and test sample were added to the 90 ul reaction mixture (final volume 
100ul) in the well plate as follows (Table 3.2).  
 Table 3.2 Sample preparation for ATP assay  
 
 
The luminescence was read. The background luminescence was subtracted. Then the 
standard curve was generated for the series of ATP concentration. The amount of ATP in 
the experimental samples was calculated using the standard curve.  
I.  90 ul reaction mix + 10ul of A   
II.  90 ul reaction mix +10ul of B  
III.  90 ul reaction mix +10ul of C  
IV.  90 ul reaction mix +10ul of D  
V.  90 ul reaction mix +10ul of E  
VI.  90 ul reaction mix +10ul of F  
VII.  90 ul reaction mix +10ul of G  
VIII.  90 ul reaction mix +10ul of H  
IX.  90 ul reaction mix +10 ul lysate of 0 h  
X.  90 ul reaction mix +10 ul lysate of 1h   No CCCP was added 
XI.  90 ul reaction mix +10 ul lysate of 2h   
XII.  90 ul reaction mix +10 ul lysate of 3h   
XIII.  90 ul reaction mix +10 ul lysate of 1h  
XIV.  90 ul reaction mix +10 ul lysate of 2h    20 uM CCCP was added 




3.3 Results and discussion   
 In vivo degradation of MurA-ssrA  
MurA is an E.Coli cytosolic protein and essential enzyme in peptidoglycan biosynthesis. 
Its depletion causes cell lysis and this can be observed in cultures by following a drop of 
optical density.78 In this experiment, MurA-ssrA was used as a soluble substrate of ClpXP 
to identify the effect of PMF on the degradation activity of ClpXP. We introduced ssrA tag 
to genomic MurA in the E.coli ΔClpX strain. Cells containing murA-ssrA displayed the 
same growth rate as wild-type cells in the absence of ClpX induction, indicating that ssrA 
tag does not affect the regular MurA function (data is not shown). Then we induced ClpX 
expression using a plasmid and read the OD600 values of the cultures without CCCP and 
containing CCCP.  In this experiment, MurA-ssrA degradation by ClpXP caused notable 
cell lysis at around 150 minutes (Figure 3.4 A and B). The time taken for ClpXP to degrade 
MurA-ssrA might probably reflect the high abundance of this endogenous protein and the 
time needed for arabinose-induced ClpX expression.  The cell lysis was visible in the ClpX 
induced samples without CCCP. In those samples, cell debris could be observed at the 
bottom of the wells and the liquid culture gradually started to become translucent after 
some time (Figure 3.5). Even though cell lysis is not apparent in samples with CCCP, the 
shape of the plots indicates the drop of optical density, proving that ClpXP activity has 
been induced.  CCCP affects the growth rate of the bacteria. However, ClpX un-induced 
cultures show a steady increase in the optical density in CCCP's presence, in contrast to the 
ClpX induced cells. 40 µM CCCP inhibits the growth compared to 20 µM CCCP.  These 
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results suggest that ClpXP is active even when the proton motive force is partially 
dissipated or wholly dissipated.  
 
Figure 3.4 Growth of MurA-ssrA strains under ClpX induced/uninduced conditions in the 
presence/absence of CCCP. 
 
Protease-driven depletion of MurA-ssrA is visible around 150 minutes A. 20 uM CCCP 
was used in relevant samples. B. 40uM CCCP was used in relevant samples.  
 
Figure 3.5 Four cells in each column represent the same experimental sample.  






 In vivo degradation of GFP-ssrA   
We used GFP ssrA as another soluble substrate to study the PMF effect on ClpXP activity. 
Plasmid-born GFP ssrA expression was induced using IPTG for 30 minutes and then IPTG 
was removed from the growth medium to prevent the further expression of GFP ssrA. 
Proteins were extracted from the cultures collected every 30 minutes and resolved using 
SDS PAGE to observe the fluorescence protein.  
Figure 3.6 A shows that WT GFP protein expressed in the DL41(DE3) WT strain lasted 
90 minutes and the left panel of figure 3.6 B shows that GFP ssrA expressed in the ΔClpX 
strain behaves similarly. On the contrary, GFP ssrA protein expressed in DL41(DE3) WT 
strain degrades within 90 minutes (right panel of Figure 3.6 B). These results show that 
ClpX actively engages in the degradation of GFP ssrA. When the experiment is repeated 
in the presence of 20 uM and 40 uM CCCP, GFP ssrA was degraded within 90 minutes 
behaving similarly to the CCCP-less conditions (Figure 3.6 C). This result proves that 
proton motive force or the ATP provided from oxidative phosphorylation is unnecessary 
for the degradation of soluble substrate GFP ssrA by ClpXP.   
 
 








Figure 3.6 A and B.  Protein degradation in the absence of CCCP-  
Wild type GFP protein expressed in DL41(DE3) WT strain and GFP ssrA expressed in Δ 
ClpX DL41(DE3) lasted over 90 minutes while GFP ssrA expressed in the DL41(DE3) 
WT strain was almost completely degraded. C. Protein degradation in the presence of 
CCCP- GFP ssra expressed in DL41(DE3) WT degraded by 90 minutes similar to  the 











 In vivo degradation of CAT-ssrA  
We further investigated the effect of PMF on the soluble protein degradation by ClpXP, 
using the soluble substrate Chloramphenicol Acetyl Transferase (CAT) ssrA. IPTG- 
inducible plasmids expressing CAT ssrA were introduced into the strains. Degradation of 
CAT ssrA was indicated by bacteria losing the resistance to chloramphenicol.   In Tables 
3.3 A and B, the OD 600 values are given. These data are obtained from four replicates of 
each experiment. Yellow highlights indicate that the cell growth was visible.  In the absence 
of IPTG, chloramphenicol and CCCP, both ΔClpX DL41(DE3) and DL41(DE3) WT with 
CAT ssrA plasmid grew well in medium X (Tables 3.3 A and B), indicating healthy 
bacterial cells. 
Moreover, only in the presence of CCCP did both cell strains grow well, confirming that 
CCCP did not affect cells' growth. ΔClpX DL41(DE3) cells with pET28a CAT ssrA showed 
chloramphenicol resistance only in the presence of IPTG, proving CAT ssrA provides 
antibiotic resistance. Chloramphenicol resistance of these cells was apparent in the 
presence and absence of CCCP. On the contrary, DL41(DE3) WT with CAT ssrA plasmid 
did not show the antibiotic-resistance when induced with IPTG in the presence and absence 
of CCCP. These results confirm that ClpXP actively degrades CAT ssrA in the presence or 








Table 3.3  Determining if ClpX is active at 20uM CCCP concentration by observing 
chloramphenicol resistance of cells.  
+ symbol indicates that the component in the relevant rightmost cell is added and – means 
the component is not added. Yellow highlights indicate that the bacterial growth was 
visible to the naked eye. A. OD 600 values of ΔClpX DL41(DE3) transformed with CAT 
ssrA plasmid in medium X. B. OD 600 values of DL41(DE3) WT transformed with CAT 
ssrA plasmid in medium X.  









Additionally, we tested the MIC of the test bacterial cultures and the positive and negative 
controls in the presence of CCCP. Table 3.4 shows the results of the MIC test. DL41(DE3) 
WT without the plasmid has the lowest MIC, 6.5 ug/ml, compared to other strains proving 
that CAT or CAT ssrA is the reason for the chloramphenicol resistance of cells. However, 
pET28a CAT in DL41(DE3) has a higher MIC (200 ug/ml) than the MIC of pET28a CAT 
ssrA in ΔClpX DL41(DE3) (50ug/ml). These results show that CAT ssrA might be 
degraded in ΔClpX strain by other proteases. However, CAT ssrA induced wild type strain 
MIC (25 ug/ml) is lower than that of ΔClpX strain (50ug/ml), indicating degradation of 
CAT ssrA by ClpXP in the presence of 20 uM CCCP. These results further prove that PMF 
is not needed for ClpXP to degrade soluble protein substrates.  
- - - + + + 20 uM CCCP 
- - + - - + IPTG 
 - + + - + + Chloramphenicol 
0.66±0.03 0.052±0.003 0.42±0.12 0.61±0.04 0.048±0.003 0.42±0.11 
OD 600 
- - - + + + 20 uM CCCP 
- - + - - + IPTG 

























 Pulse-chase studies of membrane proteins  
One of our previous studies reported that ClpXP is also capable of degrading membrane 
proteins with large cytoplasmic domains.19 We were curious if the degradation of 
membrane proteins by ClpXP is affected by the PMF. We utilized the pulse-chase method 
to study real-time degradation of plasmid born membrane protein substrates AcrB-YALAA 
(AcrB-5aa ssrA) and YajR- AANDENYALAA (YajR-11aa ssrA). As described earlier, 
YALAA is the last five residues in the ssrA tag that is responsible for ClpX binding.  
Results from the pulse-chase experiments show that membrane proteins AcrB-5aa ssrA 
and YajR -11aa ssrA degradation are delayed in the samples with 30 uM CCCP (Figure 
3.7). These results provide evidence that perhaps membrane protein degradation by ClpXP 
depends on the proton motive force. However, this delay in degradation also can be due to 
that ClpX has to overcome the high energy barrier for extraction and unfolding of stably 
anchored integral membrane proteins in the lipid bilayer and the ATP provided from 
substrate-level phosphorylation is not sufficient for this. The work published by Kenniston 
and co-workers also supports the latter reasoning.25 In this work, they report that ssrA-
Strain  Chloramphenicol MIC ug/ml 
pET28a Cat ssrA in ΔClpX DL41(DE3) 50 
pET28a Cat ssrA in DL41(DE3) WT strain 25 
pET28a Cat in DL41(DE3) 200 
DL41(DE3) WT without the plasmid 6.25 
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tagged titin protein variants with different stabilities are degraded by ClpXP; however, total 
ATP consumption is increased with increased substrate stability.25 Therefore, further 
investigations should be carried out to confirm the sole dependency of ClpXP on proton 
motive force when degrading membrane protein substrates.   
 
Figure 3.7 Pulse-chase for the membrane protein substrates. AcrB-ssrA, Yajr-ssrA is not 
degraded with time when CCCP is present (indicated by the red arrow). 
 
 ATP assay to evaluate cellular ATP level in the presence of CCCP.  
CCCP is an uncoupler that can disrupt the coupling between the electron transport chain 
and the ATP synthase. Since ClpXP is an ATP-dependent protease, drastic changes in 
cellular ATP level itself could cause a significant impact on ClpXP. Therefore, we needed 
to study how CCCP affects the cellular ATP level. For this, a bioluminescence assay for 
the quantitative determination of ATP, which utilized recombinant firefly luciferase and 
luciferin was used. Luciferase reacts on with its substrate luciferin in the presence of ATP, 
producing light which is measurable using a luminometer. We used the cell strains with 
MurA-ssrA mutation with other strains because we also needed to know if the delay of the 
observations, as seen in figure 3.4, is caused due to the variation of cellular ATP 
concentration with time. The standard curve was generated for the series of ATP 
concentrations (Table 3.5 and Figure 3.8). The results were obtained from 3 replicates of 
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the experiment. Then the luminescence of test samples was measured, and ATP 
concentrations were calculated. The average result of three replicates is presented in table 
3.7.  The results and calculations of 1 of the 3 trials as representative data are presented in 
table 3.6. The ATP concentration of each sample was calculated considering cytoplasmic 
volume is 0.67x10-15 L.79   
Table 3.5 Luminescence of ATP standards  













Table 3.6 Calculation of the cellular ATP concentration using the data of 1 of the 3 trials.  
(The cells strains are presented as WT, dX and MS where WT means Dl41 (DE3) wild type 
cells, dX means ΔClpX Dl41 (DE3) cells and MS means ΔClpX Dl41 (DE3) cells with 
MurA-ssrA mutation. Number 20 is written at the end of the strain name where 20 uM 
CCCP is used.) 










n of ATP in 
1ml of 











in a cell 
/mMg 
WT-0 0.173 5995 19.8884 198.884 1.98884E-10 1.38E8 1.44119E-18 2.15 
WT-1 0.604 18978 67.6291 676.291 6.76291E-10 4.83E8 1.40019E-18 2.09 
WT-2 1.008 9551 32.9644 329.644 3.29644E-10 8.06E8 4.08988E-19 0.61 
WT-3 1.244 12417 43.5032 435.032 4.35032E-10 9.95E8 4.37218E-19 0.65 
WT20-1 0.286 7664 26.0256 260.256 2.60256E-10 2.29E8 1.13649E-18 1.70 
WT20-2 0.418 6976 23.4957 234.957 2.34957E-10 3.34E8 7.03464E-19 1.05 
WT20-3 0.636 5242 17.1195 171.195 1.71195E-10 5.09E8 3.36336E-19 0.50 
dx 0 0.172 5322 17.414 174.14 1.7414E-10 1.38E8 1.26188E-18 1.88 
dx 1 0.719 3786 11.7656 117.656 1.17656E-10 5.75E8 2.04619E-19 0.31 
dx 2 1.090 4146 13.0894 130.894 1.30894E-10 8.72E8 1.50108E-19 0.22 
dx3 1.386 3450 10.5300 105.300 1.053E-10 1.11E9 9.48649E-20 0.14 
dx20-1 0.357 3700 11.4493 114.493 1.14493E-10 2.86E8 4.00325E-19 0.60 
dx20-2 0.421 3999 12.5488 125.488 1.25488E-10 3.37E8 3.72368E-19 0.55 
dx20-3 0.577 3864 12.05239 120.5239 1.20524E-10 4.62E8 2.60874E-19 0.39 
MS-0 0.251 5084 16.5385 165.385 1.65385E-10 2.01E8 8.22811E-19 1.23 
MS-1 0.784 16381 58.0795 580.795 5.80795E-10 6.27E8 9.26308E-19 1.38 
MS-2 1.135 15280 54.0309 540.309 5.40309E-10 9.08E8 5.95054E-19 0.89 
MS-3 1.435 19523 69.6331 696.331 6.96331E-10 1.15E9 6.05505E-19 0.90 
MS20-1 0.350 5886 19.4876 194.876 1.94876E-10 2.8E8 6.95986E-19 1.04 
MS20-2 0.525 8092 27.5995 275.995 2.75995E-10 4.2E8 6.57131E-19 0.98 
MS20-3 0.826 11887 41.5543 415.543 4.15543E-10 6.61E8 6.28658E-19 0.94 
a - (0, 1, 2, 3 numbers indicate the time point of these samples were collected. E.g- WT-1 means WT sample collected after 1 hour of 
adding CCCP to the sample. 
b - obtained using the standard curve. 
c - 10 ul of the 1 ml sample mixture was added to the 100 ul reaction mixture. Hence the concentration is 10 times the value shown in 
the left column. 
d - multiplied the value in the left column by the volume. 
e - Calculated using Aglient E. coli Cell Culture Concentration from OD600 Calculator 
f - Number of ATP moles/CFU 
g - considering cytoplasmic volume is 0.67x10-15 L. 
62 
 
Table 3.7 Final results obtained from three trials.  
(The cell strains are presented as WT, dX, and MS where WT means Dl41 (DE3) wild type 
cells, dX means ΔClpX Dl41 (DE3) cells, and MS means ΔClpX Dl41 (DE3) cells with 
MurA-ssrA mutation. The number 20 is written at the end of the strain name where 20 uM 
CCCP is used.) 
A. Fluctuation of ATP concentration with time in Dl41 (DE3) cells B. Fluctuation of ATP 
concentration with time in ΔClpX Dl41 (DE3) cells with MurA-ssrA mutation C. 




per cell /mM 
WT20 -ATP 
concentration 




1 2.58±0.56 1.94±0.23 
2 1.23±0.89 1.49±0.69 













1 1.15±0.21 1.14±0.11 
2 1.05±0.19 1.19±0.39 













1 0.72±0.56 1.82±0.54 
2 0.52±0.39 0.74±0.10 






Figure 3.9 Graphical representation of ATP fluctuation in cells with the growth.  
A. Fluctuation of ATP concentration with time in Dl41 (DE3) cells B. Fluctuation of ATP 
concentration with time in ΔClpX Dl41 (DE3) cells with MurA-ssrA mutation C. 
Fluctuation of ATP concentration with time in ΔClpX Dl41 (DE3) cells 
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The ATP levels in all strains seem to reduce from about 2 mM to about 0.5 mM within 3 
hours (Table 3.7 A, B and C, Figure 3.9). The ATP level in the cell around 2h time point 
is about 1 mM. This time point is the time point where observable cell lysis occurs in the 
MurA-ssrA degradation experiment (Figure 3.6). However, data does not show that CCCP 
has affected the concentration of ATP at this time point in any of the strains. This 
observation could be due to increased ATP production through the glycolytic pathway at 
slightly acidic conditions, as mentioned in 81. However, we did not measure the pH of the 
growth media during these trials. Therefore, it is vital to monitor the growth medium's pH 
value to study the effect of CCCP on cellular ATP concentration in future trials.    
The large standard deviations show that the measurement is not precise. One of the major 
reasons is the variation of time it took to take the reading after adding the sample between 
trials. According to a study done by Gonzalez and Russel, adding 20 uM of CCCP reduced 
the ATP level of the E.coli K-12 cells from about 3mM to 1.5 mM.82 However, it is not 
clear at which growth stage of cells these data were obtained. According to Schneider and 
Gourse, the extraction method of ATP can affect the outcome of the results. 83 They report 
that extraction with formic acid showed that ATP concentration did not change with the 
growth rate of E. coli while extraction with alkali after treating cells with formaldehyde 
showed an increase with ATP level with the growth rate. As a solution, they suggest an in-
vivo method. In this method, the firefly luciferase enzyme is expressed in bacterial cells, 
and the luminescence is measured. The results obtained using this method also show that 
ATP concentration does not vary with the growth rate. 83 The results we obtained show that 
ATP concentration decrease with the growth of cells. We used the boiling water extraction 
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method described by yang and the coworkers. 77 Therefore, to avoid complications that can 
occur during ATP extraction, it is better to use an in-vivo analytical method.  
3.4 Conclusions  
As Akiyama reported, FtsH is the major protease responsible for the in vivo degradation of 
heat shock sigma factor, σ32 a cytosolic protein, while other cytoplasmic proteases 
including ClpXP, ClpAP and HslUV also play a role in the degradation of σ32. 72 Their 
work shows that the degradation of σ32 by FtsH is affected by CCCP. Moreover, they show 
that in the FtsH deleted strains, σ32 is degraded at slower pace by other proteases mentioned 
above and this FtsH independent degradation is not affected by CCCP. 72 This observation 
correlates with our results, suggesting that ClpXP is active in the absence of the proton 
motive force for the degradation of cytosolic proteins.  
As expected, ClpXP degraded the cytosolic substrates GFP-ssrA, MurA-ssrA and 
Chloramphenicol acetyltransferase-ssrA in the absence of PMF. 
However, our results indicate ClpXP might be depending on the proton motive force when 
degrading membrane protein substrates. Degradation of both membrane protein substrates 










CHAPTER 4.  Active Number of AcrB Multidrug Efflux Pumps Required for the 
Antibiotic Resistance in the Dl41(DE3) E.Coli Strain 
4.1  Introduction  
The multidrug efflux pump AcrB plays a vital role in antibiotic resistance in E. coli. In this 
study, we are interested in finding the number of active pumps of AcrB required for 
antibiotic resistance. We determined the number of active pumps by analyzing the whole 
cell lysate of DL41(DE3) E. coli cells through quantitative western blot. We introduced 
two versions of ssrA tag (AANDENYALAA, YALAA) to genomic AcrB to control the 
expression level of the protein. Then the minimum inhibitory concentration for each 
bacterial mutant was tested for several AcrB substrates. According to a previous study, 
there are about 600 AcrB subunits or 200 AcrB trimers per E.coli cell in the BW25113 
strain. 84  
AcrB multidrug exporter functions in collaboration with AcrA and the TolC channel. There 
are plenty of studies focused on the antibiotic resistance qualities of these individual 
components and the tripartite complex.  In 2009 Blair and coworkers reported that 
disrupting AcrA gene of the pathogen Salmonella typhimurium, makes these bacteria 
highly susceptible to antibiotics. 85 On the contrary, Krishnamoorthy and the coworkers 
reported that TolC is not an appropriate target for inhibition of multidrug efflux as large 
changes of TolC concentrations in the cell did not affect the antibiotic susceptibility.86 In 
this study, we investigate the effect of AcrB protein copy number for antibiotic resistance. 
Additionally, we also show that how ClpXP protease can be used as an excellent tool to 




4.2 Materials and methods  
  Genomic insertion of the ssrA tag after the acrB gene   
The kanR cassette flanked by FRT sites and the homology arms to AcrB protein was 
amplified using polymerase chain reaction (PCR) using pECT-ssrA plasmid as the 
template. Primers used for the PCR are given in Table 4.1. The linear PCR products were 
electroporated into the DL41(DE3) strain containing RED/ET expression plasmid 
according to the instructions given by the instruction manual of GeneBridges quick and 
easy gene deletion kit .87   
















Forward Primer to amplify the linear PCR fragment with 
11 amino acids long ssrA tag, AANDENYALAA and 




Forward Primer to amplify the linear PCR fragment with   
5 amino acids long ssrA tag YALAA and homology arms 





Reverse primer to amplify the linear PCR fragment with 
homology arms to AcrB 
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Then 2 colonies were picked  and Colony PCR was done to confirm the presence of AcrB 
-5aa ssrA and AcrB -11 aa ssrA insertion using Taq DNA polymerase. The same primers 
used for homology amplification were used (expected length of the products are AcrB-11 
aa ssrA- 1453 bp and AcrB-5aa ssrA – 1447 bp). The PCR samples were resolved in a 
0.6% agarose gel (Figure 4.1).  The presence of DNA bands at the expected weight 
confirmed the insertion.  
 
 
Figure 4.1The PCR products were resolved in an agarose gel.  
11 aa indicates the bands for AcrB-11 aa ssrA and 5aa indicates the bands for AcrB- 5aa 
ssrA.  
 
The insertion of ssrA tags was further confirmed by sequencing. For this, PCR products 
were purified  using the ExoSAP-IT™ PCR product cleanup reagent. Then the samples 
were sequenced at Eurofins Genomics. As shown below, sequencing results further 





Table 4.2 Sequencing results of AcrB-5aa ssrA and AcrB-11aa ssrA.  
ssrA tag sequence is highlighted in red.   
 
 
  Minimum inhibitory concentration (MIC) for several substrates of AcrB  
DL41(DE3) E. coli AcrB mutants carrying short ssrA tag with the sequence YALAA 
(AcrB-5aa ssrA ) and long ssrA tag with the sequence AANDENYALAA (AcrB-11aa 
ssrA) and wild type AcrB were incubated in concentration gradients of AcrB substrates 
erythromycin, novobiocin, rhodamine 6G, and tetraphenylphosphonium, Clarithromycin, 
Minocycline, Amikacin, Ofloxacin, enrofloxacin, Ciprofloxacin, Norfloxacin. Minimum 
inhibitory concentrations were decided using the protocol explained in 84. Briefly, a single 
colony from an agar plate was inoculated in an overnight 5 ml of Mueller Hinton Broth 
(MHB) media. The next day, the OD600 of the overnight culture was measured, and then 
Protein 
name 
Sequencing results of the mutated part of the gene 
AcrB-5aa ssrA 
(AcrB protein with 













(AcrB protein with 











cells were diluted in the fresh MHB liquid media with antibiotics as the initial 
concentration of cells become 5X10
5 
cells/ml. The cell cultures were grown in 48 well-
plates in a 37℃-incubator shaker for 16 hours before observing.  
 
 Purifying AcrB protein to be used as the standard in the Quantitative western blot 
PBAD33 AcrB was transformed into ΔB BW25113 strain and grown on LB Agar plates. 
One colony was picked from the plate and inoculated in a 5 ml overnight LB-
Chloramphenicol culture. The next day the overnight culture was diluted into a fresh 400 
ml of LB-Chloramphenicol culture and incubated at 37°C in an incubator shaker for about 
20 hours. The subsequent day cell culture was centrifuged, and the cell pellet was 
harvested. The cell pellet was lysed in a 40 ml PBS buffer using sonication. Then the cell 
lysate was centrifuged. The membrane pellet was extracted using 2.5 ml of 0.03% DDM 
in PBS buffer and the protein was purified using Ni beads. Finally, the purified protein was 
dialyzed to remove Imidazole.  
 BCA assay to calculate the concentration of purified AcrB  
Pierce TM BCA protein assay kit was used to quantify the purified AcrB protein 
concentration. The assay was performed according to the Thermoscientific Pierce TM BCA 
protein assay kit user guide. Briefly, first, diluted albumin standards were prepared. Then 
the BCA working reagent was prepared. Then 25 uL of each standard and the AcrB protein 
was pipetted into a microplate well in 96 well-plates. Then 200 uL of the working reagent 
was added to each well and the plate placed in the 37°C incubator shaker for 30 minutes. 
Then the plate was cooled to room temperature and absorbance was measured at 562 nm 
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on the microplate reader. The standard curve was generated, and the concentration of 
purified protein was calculated. 
 
  Quantitative western blot to determine the copy number of AcrB Efflux pump in 
an E.coli cell  
E.Coli mutants carrying AcrB-5aa ssrA , AcrB 11 aa-ssrA and wild type AcrB were plated 
on LB agar plates. Then 5ml LB-Kan overnight cultures for 11 aa, 5 aa and 5ml LB cultures 
for DL41 (DE3) WT cells were grown at 37°C in an incubator shaker. The next day 
overnight cultures were diluted 100 times in new LB 5 ml cultures and grown at 37°C 
incubator shaker until OD600 reached about 0.9 and the OD was measured. Cell 
concentration was equalized and centrifuged. Cell pellets were suspended in 100 µl of Tris 
buffer (50 mM Tris, pH 8.0, 100 mM NaCl, 2 mM EDTA, 2% Triton X-100 and 0.2ul of 
saturated PMSF in ethanol) and frozen using dry ice. 1/10th volume of freshly made 
10mg/ml lysozyme was added. The sample was incubated with shaking for 20 min at room 
temperature and then frozen in dry ice for about 5 min. Next, 1/10 volume of 1mg/ml 
DNAse dissolved in 1M MgSO4 was added and incubated at room temperature with 
shaking for 10 minutes. Twenty-four ul of SDS loading dye, diluted in the lysis buffer was 
added.Twenty ul of the prepared protein samples were resolved on  8% SDS-PAGE gels. 
In parallel, a series of concentrations of purified AcrB was also resolved on 8 % SDS gels. 
Then the proteins were transferred into the PVDF membrane using semi-dry transfer 
western blot. Then the membrane was incubated in 5% skim milk prepared using TBS 
buffer in room-temperature shaker for 2 hours. Next, the membrane was incubated in the 
AcrB whole antibody (1:5000 dilution) at 4°C overnight. Then the membrane was washed 
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and incubated in the Invitrogen Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary 
Antibody, Alexa Fluor 488 (1:1000 dilution) at room temperature on a shaker shaker for 
30 minutes. The membrane was washed, and fluorescence observed using a Biorad imaging 
system. The band intensities were quantified using software ImageJ. 88 
4.3 Results and discussion  
 BCA assay to determine the concentration of purified AcrB   
To determine the concentration of purified AcrB, a BCA assay was used following the 
instructions given in Pierce TM BCA Protein Assay Kit user guide. This assay is based on 
the protein’s ability to reduce Cu2+ into Cu+. Then the BCA reagent reacts with formed 
Cu+ ion to form a purple color complex which absorbs at 562nm.  The absorbance of 
series of albumin protein and the purified AcrB samples after BCA reaction is shown in 
table 4.3. Once the concentration is determined,  the purified AcrB was used as the 
standard for the quantitative western blot experiment. 












Blank Mean and Standard 
Deviation 
2000 1.555 1.684 1.649 0.092 1.629±0.066 
1500 1.243 1.255 1.279 0.092 1.259±0.018 
1000 0.928 1.111 0.914 0.092 0.984±0.109 
750 0.774 0.73 0.755 0.092 0.753±0.022 
500 0.699 0.486 0.507 0.092 0.564±0.117 
250 0.414 0.387 0.383 0.092 0.394±0.016 
125 0.266 0.224 0.3 0.092 0.263±0.038 
25 0.133 0.132 0.125 0.092 0.130±0.004 




The standard curve was generated using the Absorbance value (Figure 4.2). 
 
Figure 4.2  Standard curve for BCA assay.  
 
 
Calculated AcrB concentration from the BCA assay is 3.097 uM (351.74 ug/ml) 
considering AcrB molecular mass is 113,574 Da.  
 
 Quantitative western blot to determine the copy number of AcrB efflux pump in 
an E. coli cell  
We conducted quantitative Western blot analysis to determine the cellular concentration of 
AcrB-5aa ssrA and AcrB- 11aa ssrA. Figure 4.3 shows the images of the western blot scans 
of the standard (Figure 4.3 A) and the test samples (4.3 B). Three replicates of each sample 
were evaluated.  Protein standard is loaded from high concentrations (left) to low (right). 





A.                                                                      B.                                                     
Figure 4.3 Images of the western blot scans of the A. Protein standard samples B. the test 
samples.  
Columns 2-8 presents the standard proteins in concentrations 2.58 uM, 1.29 uM, 0.645 uM, 
0.322 uM,0.161 uM,0.081 uM, 0.040 uM. Columns 10,11,12 presents the test sample 
protein bands wild type AcrB, AcrB-5aa ssrA and AcrB-11aa ssrA respectively. Columns 
13,14,15 and 16,17,18 are replicates of the experiment. The red arrow indicates the AcrB 
protein bands. There is an additional band that appeared below the molecular weight of 
AcrB due to the non-specific binding of the primary antibody we used for western blot.   
 
 Table 4.4 shows the intensities of each protein band quantified using ImageJ 
software.88 Intensity of the same area was read for each band and its immediate 
background. Then the background reading was subtracted from the band intensity. Then 
the standard curve was generated for protein samples with a known concentration (Figure 








The area of the 
rectangle used to 
read the band 
Intensity 1 Blank Band intensity  
2.58 936 184282 33087 151195 
1.29 936 169981 35499 134482 
0.645 936 133238 47436 85802 
0.323 936 85752 45161 40591 
0.161 936 56828 35796 21032 
0.081 936 59282 49002 10280 
0.040 936 59491 54012 5479 
AcrB WT 1 936 63633 30762 32871 
AcrB-11aa ssrA11aa 1 936 29496 26646 2850 
AcrB-5aa ssrA 1 936 27899 23597 4302 
AcrB WT 2 936 57762 25375 32387 
AcrB-11aa ssrA11aa 2 936 29446 26573 2873 
AcrB-5aa ssrA 2 936 34369 28780 5589 
AcrB WT 3 936 72770 37366 35404 
AcrB-11aa ssrA11aa 3 936 39909 36585 3324 
AcrB-5aa ssrA 3 936 42396 37344 5052 
a- 1,2,3 numbers after the sample names represent the trial number of the experiment. 
 




The standard curve (Figure 4.4) was utilized to calculate the protein concentrations of test 
samples (Table 4.5) 
 














0.969 7.75E8 4.89 0.253 3.6432E-11 2.19399E13 5789.26 
11 AA 1 0.947 7.58E8 5.00 0.027 3.888E-12 2.34141E12 617.78 
5AA 1 0.950 7.60E8 4.98 0.038 5.472E-12 3.29532E12 870.67 
DL41(DE3) 
wt 2 
0.969 7.75E8 4.89 0.249 3.5856E-11 2.1593E13 5697.73 
11 AA 2 0.947 7.58E8 5.00 0.028 4.032E-12 2.42813E12 640.66 
5AA 2 0.950 7.60E8 4.98 0.048 6.912E-12 4.1625E12 1099.79 
DL41(DE3) 
wt 3 
0.969 7.75E8 4.89 0.272 3.9168E-11 2.35875E13 6224.03 
11 AA 3 0.947 7.58E8 5.00 0.031 4.464E-12 2.68828E12 709.30 
5AA 3 0.950 7.60E8 4.98 0.044 6.336E-12 3.81563E12 1008.14 
a – obtained by using Agilent E. coli cell culture concentration from OD 600 calculator 
b – taken from the bacterial culture/ml 
c – calculated using standard curve /uM 
d – multiplying the number of protein moles by Avogadro’s number 
e – Number of copies/ (Cells/ml x volume of the cell culture) 
 
The mean value of the copy number was obtained using the data from table 4.5 (Table 
4.6) 
 
 Table 4.6 AcrB protein copy number statistics  
Sample Copy number 
AcrB WT 5903±281 
AcrB-11aa ssrA 655±47 
AcrB-5aa ssrA 992±115 
 
According to the data, the number of AcrB subunits in the DL41(DE3) strain is 
approximately 5903±281 while AcrB AANDENYALAA subunits and AcrB YALAA 
subunits are 655±47 and 992±115, respectively. These values are considerably higher 
compared to the numbers reported by Wei Lu and coworkers. 84 They reported roughly 600 
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AcrB subunits or 200 AcrB trimers per E. coli cell in the BW25113 strain. This difference 
can be due to the two different strains of E. coli. Another reason can be the different growth 
phases of the bacterial cells that were tested. In this work, bacterial cultures were harvested 
during the late growth phase (OD600 ~0.9), while Wei Lu and the coworkers used the 
overnight cultures for their experiment where cells are in the late stationary phase.84 The 
difference in the sample processing can also cause an effect on the variation of AcrB copy 
number between the two studies. Wei Lu and the coworkers analyzed isolated membrane 
vesicles 84while in this study, the whole-cell lysate was resolved in the SDS gels for 
analysis.   
The qualitative and quantitative western blot data from this work show that ssrA tag 
significantly lowered the expression level of the AcrB protein. A previous study reports 
that ssrA-tagged AcrB is degraded by ClpXP protease. 20 Therefore, we can conclude that 
ClpXP can be used to control the expression level of the antibiotic target AcrB. Another 
important observation is the number of copies of AcrB YALAA is higher than that of AcrB 
AANDENYALAA. Unlike AcrB YALAA, AcrB AANDENYALAA degradation by 
ClpXP is stimulated by adaptor protein SspB because AcrB AANDENYALAA bears the 
specific affinity sequence AANDEN to bind with SspB. SspB adaptor enhances the 
delivery of ssrA-tagged proteins specifically to ClpX unfoldase. According to a previous 
study, In-vitro degradation rate of GFP-ssrA  by ClpXP was stimulated 10 times or more 
in the presence of SspB. 27 However, Qian Chai and coworkers report that 80%- 90% of 
the plasmid born AcrB-ssrA degraded by bacterial proteases in-vivo in the absence of sspB 
. 20 Our results show that about 88% of the genomic protein degraded when SspB 
participated in the degradation while 83% of the protein degraded in the absence of SspB.  
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One of the significant limitations of the method we used to calculate the copy number of 
proteins is the possible error caused by the method we used to calculate the cells per 1ml 
(colony-forming unit/CFU) of cultures. Instead of converting OD600 into cells per ml, a 
more reliable method is to use the serial dilution method. In this method, the bacterial 
culture is serially diluted and plated to obtain a countable number of colonies. Since each 
colony on the agar plate is grown from a single bacterium, and the dilution factor is known, 
by counting colonies, CFU can be determined.  
 Minimum inhibitory concentration  
Then we tested the correlation between the copy number of AcrB and the susceptibility of 
bacteria in several AcrB substrates by observing the minimum inhibitory concentration 
(MIC) of each substrate (Table 4.7). As expected, the cells with wild-type AcrB showed 
higher resistance to the antibiotics, while cells with ssrA-tagged AcrB showed higher 
susceptibility. These results show that a higher copy number of AcrB reduce the 
susceptibility of cells to antibiotics. AcrB AANDENYALAA and AcrB YALAA reported 
similar MIC values for antibiotics erythromycin, rhodamine 6G (R6G), 
tetraphenylphosphonium (TPP) minocycline, amikacin, ofloxacin, enrofloxacin, 
ciprofloxacin and norfloxacin. Cells with AcrB AANDENYALAA were two times more 
susceptible to Clarithromycin when compared to cells with AcrB YALAA. One of the 
notable observations is Novobiocin resistance of cells with AcrB YALAA is eight times 
higher than that of cells with AcrB AANDENYALAA. Quantitative western blot results 
show that the copy number of AcrB protein is about 5-9 times the copy numbers of ssrA- 
tagged proteins. However, MIC values of cells with AcrB are not exactly 5-9 times the 
MIC values of cells with ssrA- agged proteins for most tested antibiotics. This observation 
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confirms that antibiotic resistance does not solely depend on the copy number of an efflux 
pump.  
Table 4.7 MIC of different AcrB substrates  
 






DL41 (DE3) ΔB 
Erythromycin(µg/ml) 80 5 5 2.5 
TPP(µg/ml) 1280 320 320 5 
RG6(µg/ml) 2560 320 320 10 
Clarithromycin (ug/ml) 512  16 8 8 
Minocycline (ug/ml) 2 0.125-0.25 0.125-0.25 0.25 
Amikacin(ug/ml) 4 2 2 1 
Ofloxacin (ug/ml) 0.062 0.031 0.031 0.0078 
enrofloxacin (ug/ml) 0.062 0.0078 0.0078125 0.0020 
Ciprofloxacin (ug/ml) 0.016 0.0039 0.0039 0.0020 
Norfloxacin (ug/ml) 0.062 0.031 0.031 0.031 




4.4  Conclusions  
This work confirms that AcrB efflux pump is an excellent target for the inhibition of 
multidrug efflux. One of the significant difficulties face by antibiotic development 
industries is target identification.89 One popular method is decreasing the expression level 
of a target protein to increase the potency.90 This work demonstrates how ClpXP can be 












CHAPTER 5. Conclusion and future directions 
 
E. coli cytoplasmic protease complex ClpXP is a vital regulatory system required to 
maintain cellular homeostasis. In this study, we have examined its mechanisms when 
degrading membrane and soluble protein substrates and its applications in managing the 
expression levels of targeted membrane and soluble proteins. 
In the second chapter, we showed that despite ClpXP being a cytoplasmic protease, it is 
capable of degrading ssrA-tagged membrane proteins with the large cytoplasmic domain. 
This discovery unveils numerous possible ways of utilizing the ClpXP degradation system 
as a powerful research tool. For instance, in the fourth chapter, we took advantage of ClpXP 
to demonstrate that membrane protein and multidrug efflux pump AcrB is an excellent 
antibiotic target. We showed this by introducing ssrA tag to genomic AcrB and reducing 
its expression level by subjecting it to degradation by ClpXP. Low copy number of AcrB 
increased the bacterial antibiotic susceptibility. One popular method used by antibiotic 
development industries to overcome target identification difficulties is decreasing the 
expression level of a target protein to increase the potency.89,90 Our work demonstrates how 
ClpXP can be used to manage the expression level of antibiotic targets for such 
experimental purposes.  
In this study, we have only used MIC data to conclude that a lower copy number of AcrB 
increases the bacterial susceptibility to antibiotics.  As a further investigation to prove that 
the AcrB-ssrA-ClpX system is efficient in inhibiting the multidrug efflux, quantifying 
efflux would be expedient. Efflux quantification can be monitored using fluorescent-based 




In chapter 3 we revealed that ATP-dependent protease ClpXP does not depend on the 
proton motive force when degrading cytoplasmic substrates. However, our results also 
indicated that ClpXP might be depending on the proton motive force when degrading 
membrane protein substrates. Further investigations should be carried out to prove if the 
dependence on PMF is due to lack of potential across the membrane or lack of ATP from 
oxidative phosphorylation because ClpXP is an AAA+ protease that needs ATP for its 
function. To resolve this mystery, the same experiments should be carried out in an F1Fo 
ATP synthase deficient strain. 93 The F1Fo ATP-synthase couples the PMF and ATP 
synthesis.  If AcrB-ssrA and YajR-ssrA are degraded by ClpXP in the absence of CCCP 
and this degradation is prevented by CCCP in the F1Fo ATP synthase deficient strain, it 
can be concluded that PMF stimulates the degradation of membrane proteins by ClpXP.    
Another way to avoid the effect of cellular ATP level on the experiments using uncouplers 
like CCCP in the future is maintaining the pH level at about 5.5 in the culture media.  A 
very recent study shows that E.coli increases the ATP production in cells mainly via a 
glycolytic pathway in a weakly acidic medium.81 According to this study, when 30 uM 
CCCP is added to E. coli cells at pH 5.5 (weakly acidic medium), the ATP concentration 
level decrease was insignificant. However, at pH 7.5, ATP level was significantly reduced 
by CCCP. 81 General pH values preferred by most bacteria for their growth lie between pH 
5- pH 9.94Therefore, by maintaining the pH level at about 5.5 in the culture media during 
the experiment, the effect of changes in ATP concentration on ClpXP can be avoided.   
AcrB-ssrA and YajR-ssrA used in the PMF effect studies are plasmid- borne. 
Overexpressing these ClpXP substrates can affect the outcome of the experiment. 
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Therefore, it is advisable to use protein substrates expressed in basal levels for future 
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